Search results for:
2025 Copenhagen (Denmark)
Presentations
August 30
Digital Summit (SAAP-01)
AI for drug development in pharmaceutical sciences
AI in pharmacy – real applications making a difference today
Background services running seamlessly: pharmacy around the patient 24/7
Healthy ageing: Leveraging technology for quality of life in community
How should pharmacy cope with Martec’s Law? The solution a digital strategy for pharmacy?
How to capture and use data in pharmacy practice
Key note presentation - Connected care: Pharmacists on the frontier of digital health
The prescription for learning health systems: Assessing readiness to transform pharmaceutical care
PharmClarity: Advancing Health Literacy in Pharmacy Care
Closing Session: Imparting knowledge for self-care
Culturally competent care – health literacy as a human right
Culturally competent care – health literacy as a human right
Keynote address: Global cross-sector prospectives
Plenary: A three-lens approach to health literacy
Plenary: A three-lens approach to health literacy
Tech to help or tech to harm - the place of augmentation for health literate care delivery
Tech to help or tech to harm - the place of augmentation for health literate care delivery
Tech to help or tech to harm - the place of augmentation for health literate care delivery
PPR SIG 2025 Meeting (SAAP-05)
Keynote 1 - Pharmacist Prescribing Trials: Shaping the Role of Pharmacy in Healthcare
Keynote 2 - Learnings from developing and implementing an AI enabled digital solution: a journey from concept to clinical practice
Keynote 3 - A Picture is Worth a Thousand Words: Mapping the Current and Future Landscape of Pharmacy Practice
August 31
FIP AIM Global Academic Leaders Forum 2024 (GALF) (Event for academic pharmacy leaders)* (SUAP-01)
Pharmacy in Denmark (SULS-01)
September 1
Advancing safe and responsible antibiotic access: The integration of the community and hospital settings (PSMO-03)
Insights for hospital and community pharmacists
Why AMR needs all of us: Insights from the EU-JAMRAI project – a multidisciplinary approach to tackle AMR
Deprescribing: Facts and controversies of promoting sustainable practices and personalised care in an ageing population (PSMO-07)
Big data: Data analytics to identify deprescribing opportunities and influence healthcare
Deprescribing: Aligning treatment with life expectancy, patient preferences, and quality of life
Streamlining medications in older adults: A guided approach to safe deprescribing
Education can save lives: Point-of-care-testing (POCT) for early detection in pharmacy and innovative approaches in pharmacy practice (PSMO-06)
Educating and certifying pharmacists to provide point of care testing (POCT): The power of clinical decision for early detection
Embedding environmental sustainability at the heart of pharmacy practice (PSMO-10)
Greener pharmacy: Embracing sustainability in community pharmacy practice
Innovations in sustainable pharmacy: Leadership and technologies for the future
Emerging challenges in antimicrobial resistance (AMR) and the role of pharmacists in vaccination and resistance to antifungals (PSMO-01)
Antifungal resistant fungal infections: Danish and global scenario
Antimicrobial resistance and the economics of public health
The role of pharmacists and the need for antifungal stewardship
Find your digital health zen: How to digitally innovate with care (PSMO-08)
The range of digital health, telehealth and mobile applications being used in healthcare and pharmacy
What pharmacists need to be aware of to meet their regulatory and ethical obligations
Integration and innovation: Advancing equity in pharmacy education (PSMO-09)
Opportunities and experiences from UNITWIN Centre for Excellence: South East Asia
Opportunities and experiences from UNITWIN Centre for Excellence: Western Pacific Region
Opportunities and experiences from UNITWIN Centre for Excellence: Western Pacific Region
Novel antimicrobials in the pipeline and the use of computational medicinal chemistry in finding new antimicrobial agents (LSMO-01)
Developing the next generation antibiotics – challenges and opportunities
The use of clustered regularly interspaced short palindromic repeats (CRISPR) technology in developing novel treatments against infection diseases
Pharmacist storytelling: Real-world impact of digital health (PSMO-05)
Reshaping community pharmacy: Strategic responses to global health dynamics (PLMO-01)
The global threat of antimicrobial resistance (AMR)
The socio-economic aspects of antimicrobial resistance (AMR)
Sharing ideas of member organisations: American Society of Health-System Pharmacists, USA & Advanced Pharmacy Australia, Australia (MOMO-01)
Sharing ideas of member organisations: Indian Pharmaceutical Association, India & Association of Pharmacists Belgium, Belgium (MOMO-03)
Belgian community pharmacies’ investments in digitalisation to assure our sustainable future and develop added value pharmaceutical services to patients
Rational use of medicines in developing countries: A case study of India
Sharing ideas of member organisations: Norwegian Pharmacy Association, Norway & Rwanda National Pharmacy Council, Rwanda (MOMO-02)
Enhancing pharmacy practice through unified efforts and close cooperation in Norway
Rwanda’s 4x4 strategy to transform the pharmaceutical workforce: Lessons and innovations for enhanced capacity
Sharing ideas of member organisations: Portuguese Pharmaceutical Society, Portugal & General Pharmaceutical Council of Spain, Spain (MOMO-04)
Should I stay or should I go? Building an agile and resilient pharmacy workforce (PSMO-04)
Building flexibility and resilience for future pharmacists
Effective strategies for building lasting careers in pharmacy
The ethics of pharmacist prescribing: An examination of responsibilities involved in expanded practice (PSMO-02)
Navigating the prescribing landscape
The ethics of prescribing – building and maintaining trust in the profession of pharmacy
September 2
3D printing: is it the future of pharmacy and pharmaceuticals? (PSTU-02)
3D printing in pharma industry, and translation to clinics
Pharmacy compounding with 3D Printing technology: Real world use cases from hospital pharmacies in Europe and USA
Tailor‐made doses of pharmaceuticals by tunable modular design
AI as a cost-effectiveness accelerator in drug research and development (PSTU-08)
AI-powered drug discovery: faster hits, better PK, lower costs
Use case of artificial intelligence in clinical trial optimisation
Bridging innovation and equity: Advancing pharmaceutical development for global health access (PLTU-03)
Children are not just small adults! Tailoring science and pharmaceutical care to our youngest patients (PSTU-10)
Distinguished Pharmaceutical Science Award Lecture (LSTU-03)
Enhancing pharmaceutical care for the silver generation: Leveraging AI and data sharing to address polypharmacy (PSTU-05)
Learning from Japanese community pharmacies and Australian hospitals: Cutting-edge approaches to polypharmacy in older adults and big data utilization
The current state and challenges of data sharing in Europe and the potential of AI utilisation
From lab bench to pharmacy shelf: Pharmacists bridging drug development and patient outcomes (PSTU-04)
Pharmacists as evidence-based health educators: How to communicate science to patients to achieve better outcomes
Pharmacists as evidence-based health educators: How to communicate science to patients to achieve better outcomes
Precision medicine: Pharmacists’ key role in personalising drug therapy
New biologics and biosimilars: The new biologics and biosimilars: Advances in peptide drug design and GLP-1 agonists (PSTU-07)
Machine-learning-guided development of GLP-1R agonists
Peptide drug design applied to novel biologics and biossimilars developmenT
Pharmaceutical scientists in cancer research: From new drugs to better disease modelling and treatment efficacy (PLTU-02)
From beside to bench and back: How patient-derived organoids and 3D models can improve cancer research and therapy decisions
Implementation of PGx and policies affecting change in the US
Leverage the power of AI for precision & personalised medicine
Pharmacists in global health: Bridging healthcare and peace (PSTU-09)
Health advocacy in action: Overcoming barriers to access to medicines and care in conflict zones
Healthcare delivery in conflict zones: Ensuring continuity amid crisis
Regulatory harmonisation: Successes and challenges along the pathway to regulatory convergence (PSTU-03)
Bioclassification System-based (BCS) biowaivers (ICH M9)
How globally harmonized regulatory approaches can facilitate patient access to affordable medicines
Remote patient monitoring and digital measures in clinical trials: Enhancing efficiency, engagement and validity (PSTU-06)
Digital measures for research: impact on patient engagement and
Enhancing clinical trial efficiency with remote patient monitoring
Reshaping community pharmacy: Strategic responses to global health dynamics (PLTU-01)
Critical indicators for community pharmacy transformation: Insights beyond 2025
Pharmacists’ strategic response to changing health care landscapes in the Americas
Shaping global self-care policies: A dialogue with leaders on the future of self-care (PSTU-01)
Sharing ideas of member organisations: American Pharmacists Association, USA & French Chamber of Pharmacists, France (MOTU-01)
Advocacy and Education to Advance the Pharmacy Profession: American Pharmacists Association
Pioneering initiatives of the French Chamber of Pharmacists regarding attractivity, security and the recognition of new missions in France
Sharing ideas of member organisations: Pharmaceutical Chamber Of Montenegro, Montenegro & Association of Community Pharmacists of Nigeria, Nigeria (MOTU-04)
Pharmaceutical care and pharmaceutical services as an integral part of new pharmacy law in Montenegro
Standardisation: Career progression ratings for community community pharmacists in Nigeria
Sharing ideas of member organisations: Pharmaceutical Society of Australia & Saudi Pharmaceutical Society, Saudi Arabia (MOTU-03)
Sharing ideas of member organisations: Pharmaceutical Society of South Africa, South Africa & Canadian Pharmacists Association, Canada (MOTU-02)
Advancement of pharmacy-based primary care in Canada
Primary care drug therapy (PCDT) pharmacists in South Africa
September 3
Adapting military practices to strengthen civilian response and population health (PSWE-08)
Designing military rations based on principles of balanced nutrition
In officio salutis: in the service of health on land, air, and sea for humanity
Strategies and challenges in valuing first-aid pharmaceuticals
Closing session (PLWE-02)
Drug shortages in oncology: Challenges and solutions for ensuring healthcare security (PSWE-06)
Global shortage in oncology: challenges and opportunities to manufacturers and regulatory agencies
Promoting safe and effective medication access during drug shortages: the role of clinical pharmacists and health systems on a cancer patient’s journey
Enhancing pharmacy education and professional development through AI (PSWE-03)
How AI enhances pharmacy education by bridging educational gaps, addressing ethical considerations and supporting pharmacists’ continuous professional development
Use of AI learning tools, how they can be used in different pharmacy settings, and their place in standardisation and assessments
FIP Regional Forums advancing pharmacy through global collaboration (LSWE-05)
Africa – Presentation of key projects and priorities
Africa – Presentation of key projects and priorities
Africa – Presentation of key projects and priorities
Americas – Presentation of key projects and priorities
Americas – Presentation of key projects and priorities
Eastern Mediterranean – Presentation of key projects and priorities
Eastern Mediterranean – Presentation of key projects and priorities
Southeast Asia – Presentation of key projects and priorities
Western Pacific – Presentation of key projects and priorities
Healing heroes: Military pharmacists in action (PSWE-04)
Compassionate response: Malaysian Armed Forces Hospital medical aid to injured Palestinians
Policy development and implementation of a military supply chain for blood
Innovative drug and vaccine delivery systems: Enhancing safety, adherence, and health outcomes (PSWE-01)
Improving therapeutic adherence and healthcare outcomes: development of a microneedle patch for self-administered, long-acting contraception
Nanotechnology-based delivery systems applied to vaccines and biological therapies: the run for personalised medicines
Making transitions of care work (PSWE-05)
Expanding the role of the pharmacy profession to improve medication management on transitions of care
Reducing disparities at transitions of care. Championing patient needs in pharmacy curricula and practice
The role of community pharmacy in post discharge medicine review in Wales: an interprofessional, evidence-based journey
New treatments for disorders of gut-brain interactions and the expanding role of pharmacists (EMWE-01)
Predicting the future: Data forecasting for pharmacists (PSWE-02)
2025 FIP Health Promotion Campaign Award presentation
Transforming practice with predictive analytics: real-world applications for pharmacists
Shaping the future of healthcare through AI education, and workforce development (PLWE-01)
Developing the healthcare workforce for the future
Navigating the future: The importance of AI frameworks in supporting the practice of healthcare workers
Sharing ideas of member organisations: Colegio de Farmacéuticos de Costa Rica, Costa Rica (MOWE-04)
Development of pharmaceutical immunisation services in community pharmacies: A case study from Costa Rica
Sharing ideas of member organisations: Malaysian Pharmacists Society, Malaysia & Irish Pharmacy Union, Ireland (MOWE-01)
Innovations in Community Pharmacy – Malaysian Pharmacists Society Driven Change in Preventive Care and Sustainability
Managing a multi-stakeholder approach to extending the role of the community pharmacist
Sharing ideas of member organisations: National Association of Pharmacies, Portugal & Brazilian Federal Council Of Pharmacy, Brazil (MOWE-03)
Advances in Pharmacy Practice: new professional roles of brazilian pharmacists in healthcare.
Transforming the Health Journey: The Expanding Role of Portuguese Community Pharmacies
Sharing ideas of member organisations: Taiwan Society of Health-System Pharmacists, China-Taiwan & Association of Danish Pharmacies, Denmark (MOWE-02)
New services in Danish Community pharmacies
Systematizing Pharmacy Support Personnel to Address Taiwan’s Pharmacy Workforce Challenges
Sustainable solutions for gender equity: Leveraging technology and regulation (PSWE-07)
Transforming the healthcare workforce: Educating future leaders in health, pharmacy, and STEM for gender equity
Wendes (PSWE-04)
Posters
PPR SIG Summer Meeting
PPRCH-01 - Pilot study on digital communication between community pharmacists and general practitioners
PPRCH-02 - Use Of Comics As A Tool To Educate Junior High School Students In The Ashanti Region; Ghana About Antimicrobial Resistance And Its Impact On Knowledge
PPRCH-03 - Determining the impact of pharmacists on treatment adherence in patients with Coronary heart disease in Ukraine
PPRCH-04 - The impact of optimizing pharmacotherapy of coronary heart disease with comorbid conditions on adherence to treatment according to the EUROASPIRE V observational study in Ukraine
PPRCH-05 - Enhancing Experiential Learning in Pharmacy Internships: A Qualitative Analysis of Patient Consultation Training
PPRCH-06 - Development and Impact of a Training Programme for Community Pharmacists on Therapeutic Education Supporting Patients with Endometriosis
PPRCH-07 - Blood pressure control in severe pre-eclamptic patients: Evaluating collaborative approaches to patient care and impact on management outcomes in a Hospital in Ghana
PPRCH-08 - Healthcare professionals’ and consumers’ awareness and understanding of the Black Triangle Scheme and its influence on adverse drug event reporting in Australia: a mixed-methods study
PPRCH-09 - Promoting Confidence and Competency in Pharmaceutical Care Practice for Pharmacy Students and Pharmacists in Taiwan through Workshops
PPRCH-10 - Impact of statin therapy on stroke patients with carotid artery stenosis: A prospective cohort analysis
PPRCH-11 - Exploring the implementation of pharmacist independent prescribing for common clinical conditions within community pharmacy.
PPRCH-12 - Integration of digital wellness programmes in pharmacies: addressing blue light exposure and nomophobia
PPRCH-13 - Preconception care interventions within a community pharmacy setting: A scoping review
PPRCH-14 - A pharmacist care pathway intervention for vascular prevention: Protocol for a randomized controlled trial, PRxOACT
PPRCH-15 - Why do patients stop taking their glucagon-like peptide-1 receptor agonists?
PPRCH-16 - Retrospective Analysis of LDL Change From Baseline in Patients Post Acute Myocardial Infarction
PPRCH-17 - Evaluation of Pain Management Following Cardiac Surgery in an Adult Critical Care Unit in London, England
PPRCH-18 - Assessment of VTE Prophylaxis Using Hematological Parameters Upon Admission at a Cancer Care Center in London, England
PPRCH-19 - A Study on Prescribing Patterns, Polypharmacy, and Antimicrobial Stewardship in a Tertiary Care Hospital for Optimizing Medication Use in Post-Operative Care
PPRCH-20 - Migraine Management in Lebanon: Assessing Economic, Clinical, and Digital Perspectives on Patient Care and Innovation
PPRCH-21 - Have antibiotics lost their prescription status? A Qualitative analysis of the supply factors in Community Pharmacies
PPRCH-22 - Development and validation of a questionnaire for assessing digital literacy among pharmaceutical specialists
PPRCH-23 - Iterative Design of a Pharmacy Simulation Tool for Enhancing Licensing Exam Readiness in Russia: Insights from Beta-Testing
PPRCH-24 - The Evolution of Pharmaceutical Services in Brazil and the Role of Technological Platforms in the Standardisation, Compliance, Recording, and Traceability of Data
PPRCH-25 - Analysis of pharmaceutical market in Ukraine: retail sales in last half a decade
PPRCH-27 - Exploring the Integration of a Digital Medication Dispenser in Community Pharmacies: A Qualitative Study with Portuguese Pharmacists
PPRCH-28 - An Analysis of Delirium and Its Management in Post Cardiac Surgery Patients in an Acute Critical Care Unit
PPRCH-29 - Analysis of Icosapent Ethyl Eligibility in Post Acute Myocardial Infarction Patients
PPRCH-30 - Interdisciplinary role profile development of hospital pharmacists: a theory informed focus group pilot study
PPRCH-31 - Improving Experiences of Transgender People within Community Pharmacies in the United Kingdom
PPRCH-32 - Impact of improvement plan on pharmacy grading outcomes: A risk-based approach to pharmacy inspections in South Africa
PPRCH-33 - Epilepsy Management in Lebanon: Exploring Economic Burden, Quality of Life, and Cost-Effectiveness in the Context of Socioeconomic Challenges
PPRCH-34 - Exploring the concept and definition of scope of practice in pharmacy: A systematic review
PPRPP-35 - Analysis of patient harm from the impact of hospital discharge orders on community pharmacists' workload in Canada
SEC - Academic Pharmacy
APS-001 - Inaugural immunization training for pharmacists in South Korea: Building on immunization education for pharmacists for public health workforce preparedness and response to optimize patient care
APS-002 - Acquisition of pharmaceutical care competencies. Student self-assessment and proposals for improvement
APS-003 - Research & training activities: Needs in community pharmacies
APS-004 - AI’m here to help! Translating preceptor expectations into student success using artificial intelligence
APS-005 - Assessment of pharmacy students' knowledge, attitudes, and practices regarding evidence-based medicine resources
APS-006 - Nothing for us without us: Successes and learning from partnership with a community-oriented advisory committee
APS-007 - A hybrid educational model for the pharmacy curriculum: lessons learned from a public health elective course in the United States of America
APS-008 - Evaluation of an international mentoring programme from the mentees' view
APS-009 - The role and perceptions of pharmacy students in a novel rehabilitation-focused clinical rotation
APS-010 - Anti-doping and sports pharmacy in pharmacy education: Integrating comprehensive knowledge and ethical practices
APS-011 - Generative artificial intelligence in health professions education: a scoping review of implementation, opportunities, challenges, and regulatory frameworks
APS-012 - Interdisciplinarity meets team teaching: shaping the future of pharmaceutical workforce education through foresight elements
APS-013 - Knowledge, attitude and practice of early-year university students towards microplastics
APS-014 - A content analysis: which antimicrobial stewardship interventions do pharmacy students resonate with the most?
APS-015 - A global investigation into antimicrobial knowledge in medicine, pharmacy, nursing, dentistry and veterinary undergraduate students: A scoping review to inform future planetary health multidisciplinary education
APS-016 - Improving patient health outcomes through a multi-institutional partnership for interprofessional education
APS-017 - Education abroad: A transformative learning experience for pharmacy students
APS-018 - Enhancing skincare expertise: Apotek1's comprehensive training and new skin analysis service
APS-019 - Data driven AI-gamification learning and rewards to enhance pharmacist engagement and professional development
APS-020 - Gamification in pharmacy education: Application in pharmacist prescribing for minor ailments
APS-021 - Engaging students in One Health: A gamified approach to interprofessional education
APS-022 - Improving antibiotic learning in undergraduates using modules based on the inn stems system
APS-023 - Analysis of compliance rates with the accreditation council for pharmacy education (ACPE) Quality criteria during initial or continued evaluation reviews
APS-024 - Revision of ACPE international-accreditation quality criteria
APS-025 - Sustainability in instructional design: Optimizing simulation-based learning by reducing cognitive overload
APS-026 - Teaching ethics in the digital era: Impact of an interprofessional education workshop on student knowledge and attitudes
APS-027 - Weight bias and stigma in healthcare: Description of an innovative interprofessional education workshop
APS-028 - Biomedical ethics teaching during times of political turmoil
APS-029 - Shaping the future of pharmacy: A unified pre-graduate education framework for lusophone countries
APS-030 - Impact of co-curricular engagement on students’ self-perceived personal and professional development: An artificial intelligence (AI)-supported metacognitive analysis
APS-031 - Uniting ten health professions: Advancing health through interprofessional education focusing on social determinants of health
APS-032 - Developing international and interprofessional collaborations through a fulbright scholar experience
APS-033 - Academic Pharmacy Section of the International Pharmaceutical Federation: Insights from the membership survey
APS-034 - Self-assessment in pharmacy law and ethics e-learning: Experience from a national capacity building programme
APS-035 - Case-based learning in clinical pharmacokinetics course
APS-036 - E-Learning and simulation to train French pharmacists for their new duties
APS-037 - Using GenAI to assess student reflections of a living with diabetes simulation activity
APS-038 - NU POET* Society [*Peer Observation Evaluation Tool]
APS-039 - French Chamber’s 360° communication campaign to boost attractiveness of the profession
APS-040 - Longitudinal interprofessional education throughout the pharmacy curriculum
APS-041 - Exploring student pharmacists’ and preceptors’ views on professional attire in the pharmacy practice setting
APS-042 - Enhancing student pharmacists’ patient interviewing skills with artificial intelligence
APS-043 - Leveraging AI as a tool in assessment and evaluation for PharmD verbal clinical simulation
APS-044 - Pharmacy students as catalysts for public health in maternal health campaigns: A case study from Ghana
APS-045 - Fostering international perspectives in leadership for pharmacy students through Global Leadership Connections (GLCs)
APS-046 - An interim assessment of simulation intensity and demonstration of ability based outcomes, transitional hand-off communication and professional assertion
APS-047 - Development of a novel community pharmacy practice transformation fellowship
APS-048 - Developing empathy to support pharmacist-patient shared decision making
APS-049 - Exploring the impact of curriculum changes on trainee development in dutch workplace-based education using self-determination theory
APS-050 - Carving a path to student success: Connecting admissions data to postgraduate outcomes using artificial intelligence
APS-051 - Modelling and factors contributing to the demography of pharmacists in France until 2050
APS-052 - The Southern California outreach for pharmacy education: A pharmacy and pharmaceutical sciences career pathways program for secondary school students
APS-053 - Evaluating the impact of a pharmacy administration and leadership short course and microcredential targeting new hospital pharmacy leaders in the Western Pacific
APS-054 - Practice-ready, team-ready, and social determinants of health-ready: An interprofessional education session with pharmacy, physical therapy, and physician assistant students
APS-055 - Pharmacists in educational research: A collaborative scholarship approach
APS-056 - Students' acceptance and use of generative AI in pharmacy education: International cross-sectional survey based on the extended unified theory of acceptance and use of technology
APS-057 - Global perspectives of educators and academic leaders on integrating computer-based simulation into pharmacy education
APS-058 - Beyond the Clinical training: Integrating Whole Health Strategies into International Pharmacy APPEs
APS-059 - Supporting neurodiversity especially in the preparation for licensure exams
APS-060 - Pharmacy students’ experiences in an interprofessional hospital ward simulation: Readiness for collaborative practice
APS-061 - Reshaping pharmacy education: Addressing curriculum overload for future-ready graduates
APS-062 - Embedding teaching on health inequities within the undergraduate pharmacy curriculum to enhance relevance and insight
APS-063 - Bringing real-world cases to the classroom: Enhancing pharmacy education with Case-Based Learning (CBL)
APS-064 - Advancing pharmacy experiential education for ambulatory antithrombotic services in the United States
APS-065 - Artificial Intelligence in health professions education: A quick review of the massive open online courses (MOOCs)
APS-066 - A scoping review of planetary health education in pharmacy curricula
APS-067 - Teamwork by design: Assessing the impact of an interdisciplinary pharmacy project on student learning and collaboration
APS-068 - Balancing focus and well-being: First investigation of attention span, mental health, and lifestyle among pharmacy students from Lebanon
APS-069 - Bridging perspectives: Impact of a virtual exchange program on mental health awareness among pharmacy students
APS-070 - Long-term Impact of international rotations on doctor of pharmacy students
APS-071 - Pharmacists and environmental responsibility: Embracing opportunities, overcoming challenges and making it sustainable through education
APS-072 - Enhancing cultural responsiveness in pharmacy education to deliver personalised care and addressing domestic violence in diverse communities
APS-073 - Evaluating microlearning's effect on social determinants of health in skills-based courses
APS-074 - Impact of a vulnerable and underserved patient care elective on pharmacy students’ perceptions of patients across citizenship status
APS-075 - Professional identity formation: Becoming a pharmacist
APS-076 - Enhancing interprofessional collaboration through skills labs: A pilot study within the pharmacy game educational model
APS-077 - Phytotherapy in pharmacy education and practice: Bridging tradition and modern healthcare in the Netherlands and Indonesia
APS-078 - Transforming pharmacy education: Integrating continuing professional development and graduate studies
APS-079 - It takes a village: Supporting professional identity formation in Canadian pharmacy schools’ curricula
APS-080 - APPE Readiness of pharmacy students after completing an advanced ippe rotation at an academic medical center
APS-081 - Incorporation of electronic health record training within the doctor of pharmacy curriculum and its impact on experiential education
APS-082 - Integrating digital health, virtual reality therapeutics, and artificial intelligence into pharmacy education
APS-083 - Promoting confidence and competency in pharmaceutical care practice for pharmacy students and pharmacists in Taiwan through workshops
APS-084 - Enhancing pharmaceutical care education through engaging case scenarios in virtual patient web platform
APS-085 - Empowering educators to enhance student engagement: Comparing the Intention/Reflection (I/R) practice pre- and post-COVID-19 pandemic
APS-086 - Expanding pharmacy horizons: A 12-month ASHP-accredited PGY1 pharmacy residency program for international graduates in the United States
APS-087 - The knowledge and attitudes of pharmacy students in Ghana on antimicrobial use, resistance and stewardship
APS-088 - Knowledge and attitudes of pharmacy interns in Ghana on antimicrobial use, resistance and stewardship
APS-090 - Equity, diversity, inclusion and accessibility in pharmacy education: A scoping review
APS-091 - Assessing the change in career pathway interest of Doctor of Pharmacy students from second to sixth year and the influencing factors: A biphasic cross-sectional study
APS-092 - Prevalence of anxiety and other associated psychosocial factors among pharmacy students in a university in Southern Nigeria
APS-093 - Prevalence and predictors of burnout among undergraduate pharmacy students in a Nigerian university
APS-094 - Evaluation of bidirectional learning between the United Kingdom and Ghana and Uganda in the practice of Antimicrobial Stewardship
APS-095 - Filipino students' experience and satisfaction with learning AI pharmacy in Taiwan: Evaluation of teaching, skill enhancement, and accessibility of AI tools
APS-096 - Exploring leadership perceptions, preparedness and development in pharmacy education: A multi-regional cross-sectional study
APS-097 - No-To-Nicotine: Empowering future pharmacists in smoking and vaping cessation
APS-098 - Expanding student engagement and feedback during experiential learning in healthcare consulting in the biopharmaceutical industry
APS-099 - Master of science degrees in biopharmaceutical marketing and healthcare decision analysis to prepare PharmD students for business careers in the healthcare and biopharmaceutical industries
APS-100 - Exploring student leaders’ motivation to engage in the interprofessional education student association: A qualitative study framed by self-determination theory
APS-101 - Distinctive features of pharmacy education in Taiwan and Malaysia: Insights for curriculum development
APS-102 - Conceptualisation, implementation, and evaluation of resilience interventions in health sciences higher education: A scoping review
APS-103 - OSCEs and clinical competence in inpatient direct patient care experiential education
APS-104 - Authentic assessment in experiential education
APS-105 - Advancements in education and continued professional development in pharmacy: The commitment of the Argentinian Association of Pharmacists of Entre Ríos to pharmaceutical education
APS-106 - From slides to visual stories: Infographic-based learning in a South African pharmacy program
APS-107 - Revitalizing problem-based learning through a rotational OSPE Model: A sustainable approach in pharmacy education
APS-108 - Interactive fiction and learning from failure in postgraduate pharmacy education
APS-109 - Integrating generative artificial intelligence in pharmacy education: Lessons from a novel clinical assessment in a global distance-learning module
APS-110 - Evaluating a 360-degree professionalism assessment tool for pharmacy students during community placement
APS-111 - Enhancing pharmacy students' application of the pharmacist patient care process and understanding of social determinants of health through simulation-based learning
APS-112 - Assessing the impact of the Africa leadership fellowship for antimicrobial stewardship: A mixed-methods evaluation
APS-113 - Collaborative learning and better perception of pharmacy – student - teacher relationship
APS-114 - How do pharmacists improve their professional careers? Pharmaceutical specialities in Argentina
APS-115 - Evaluating the Ministry of Health Foundation Training Program: Trainee perspectives and insights
APS-116 - The Impact of orientation day on first-year pharmacy and pharmaceutical science students' sense of belonging
APS-117 - A novel approach to improving the listening skills of postgraduate pharmacists utilising a relationship counselling method
APS-118 - Collaborative practice between universities: Creating sustainable infrastructure for experiential learning across large cohorts and geographies
APS-119 - A blended training approach to equipping pharmacists with requisite skills to provide medication therapy management (MTM) services in Ghana
APS-120 - Addressing the gap in oncology pharmacy services: A training initiative in Ghana
APS-121 - Evaluating education for pharmacist prescribing: Preliminary results of a realist synthesis
APS-122 - Exploring student experiences of marginalisation and inclusion in pharmacy education
APS-123 - Preparing pharmacy students to communicate effectively with adolescents: A Global PharmAlliance course
APS-124 - Knowledge and awareness of radiopharmacy and nuclear medicine among pharmacy students at a health sciences university in Gauteng
APS-125 - Advancing pharmacy technology practice through an innovative model of applied education and training in the state of Qatar
APS-126 - Reliability of entrustable professional activities in evaluating the effectiveness on pharmacist post-graduate year training
APS-127 - Digital competencies of pharmaceutical specialists abroad: trends in university education and employer expectations
APS-128 - The impact of university training on the development of digital competencies of pharmaceutical graduates
APS-129 - Differences in faculty and student perceptions of global engagement within pharmacy academia
APS-130 - Empowering pharmacists in ethical pharmaceutical entrepreneurship through the development of a training programme
APS-131 - Interprofessional education in healthcare: A simulation-based transdisciplinary model fostering trust and empathy
APS-132 - Building infection-specialist capacity of pharmacists: a cross sectional survey from 16 countries attending the multi-disciplinary European Society of Clinical Microbiology and Infectious Diseases Global conference
APS-133 - Program directors' perceptions of characteristics of the online pharmacy programs in the US
APS-134 - Tracking pharmacy students’ leadership traits using an established survey for preference and maturity
APS-135 - Challenges with the use of ChatGPT
APS-136 - Hospital pharmacy content in the undergraduate pharmacy curricula of public universities in the Southeast region of Brazil: A documentary analysis
APS-137 - What do students need to know in an era of artificial intelligence? A core concepts approach to pharmacotherapy education
APS-138 - Enhancing Canadian pharmacy education and interprofessional collaboration by using a simulated electronic health record platform
APS-139 - Integrated academic programs in education, research and advocacy advance pharmacy practice and improve healthcare
APS-140 - Pharmacy education and community training: overcoming barriers to student placement in Jordan
APS-141 - Advancing capacity to manage antimicrobial stewardship interventions in a low-income country: Pharmacist champion training in three hospitals and three community pharmacies in Sierra Leone
APS-142 - Development and validation of an interprofessional and collaborative competencies framework for primary health care: A Brazilian perspective
APS-143 - Development and implementation of a quality assurance system in a PharmD program in Saudi Arabia to achieve NCAAA accreditation
APS-144 - Determination of Warfarin in volumetric absorptive microsampling for therapeutic drug monitoring using LC-MS/MS
APS-145 - A simulation-based interprofessional program to enhance caring behaviors and collaborative skills in pharmacy students
APS-146 - Overview of breastfeeding teaching in French pharmacy universities compared with UNICEF UK Baby friendly initiative learning outcomes for pharmacy students
APS-147 - Effective examples of Interprofessional Education (IPE) and the role that trust plays
APS-148 - Exploring the professional identity formation of Black pharmacy students at the University of Toronto
APS-149 - Queering health: Lessons learned from the UBC Faculty of Pharmaceutical Sciences’ journey in becoming a champion in 2SLGBTQ+ education
APS-150 - Advocating for a designated portion of time for scholarship in pharmacy educators’ workload
APS-151 - Knowledge, attitude, and practices related to the implication of artificial intelligence in research among post-graduate pharmacy and allied health science students
APS-152 - Pharmacy Quest: A novel gamification approach to boost resident engagement and performance in ASHP-Accredited Programs
APS-153 - Advancing pharmacy education through competency-based curriculum development: Aligning graduate Skills with national and global healthcare needs
APS-154 - Transforming pharmacy education: Implementing a streamlined competency-based framework with entrustable professional activities
SEC - Clinical Biology
CBS-001 - Prevalence of Sexually Transmitted Infections (STIs) in pregnant women and breastfeeding mothers in some rural communities in Abia State, Nigeria
CBS-002 - The impact of 100% reimbursed, prescription-free hiv testing in France: Strengthening patient access and the role of medical biologists
CBS-003 - Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders
CBS-004 - Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of sitafloxacin in human plasma and bronchoalveolar lavage fluid
CBS-005 - Elucidation of the mechanism of allergic sensitization enhanced by non-steroidal anti-inflammatory drugs in a rat model
CBS-006 - Associations between serum tocilizumab level, interleukin-6, and endogenous markers of CYP3A activity in patients with rheumatoid arthritis
CBS-007 - Potential use of probiotic cell-free culture supernatants as novel antimicrobials against Gram-positive and Gram-negative bacteria
CBS-008 - Transplacental transmission and biomarkers for PFAS exposure: Findings from paired maternal and umbilical cord blood samples
SEC - Community Pharmacy
CPS-001 - Tackling loneliness: A shared challenge
CPS-002 - Pharmaceutical prevention and action in mental health in Spanish community pharmacies: Rural schools of mental health
CPS-003 - A novel multidisciplinary dermatological care model for managing patients with acne and atopic dermatitis: Consensus guidance for pharmacists
CPS-004 - Barriers and expectations of the pharmaconomists at Randers Jernbane Pharmacy prior to implementation of new medicines services
CPS-005 - Determining beyond-use dates for nonsterile compounded preparations
CPS-006 - Screening project for natriuretic peptides in the primary prevention of heart failure
CPS-007 - Non Perdiamo il Ritmo (Don't Lose the Rhythm): The role of telemedicine in Italian pharmacies
CPS-008 - Farmambiente: The pharmacy at the service of environmental sustainability
CPS-009 - Pharmacist Assistant Bot: AI empowering pharmacists
CPS-010 - Deployment of the quality system for French community pharmacies: 2024 outcomes
CPS-011 - Sports pharmacy: The new emerging role of the community pharmacists
CPS-012 - Evaluation of the "PROLAMVANO" colorectal cancer screening programme from the perspective of community pharmacists in Greece
CPS-013 - Enhancing healthcare continuity: Efficient communication of medication updates between community pharmacy and primary care: A case report
CPS-014 - French Chamber’s initiatives to support pharmacists dealing with victims of domestic violence
CPS-015 - Pharmacists' safety in practice: A daily concern for the French Chamber of Pharmacists
CPS-016 - Everyday life of Danish pharmacy
CPS-017 - Standardized medication plans/schedules: Do patients use them and are they correct?
CPS-018 - An examination of pharmacists’ unconscious biases in response to suicidal male patients: Straight, twinks and bears
CPS-019 - Dispensing of hospital-only medicines in community pharmacies: Enhancing patient access and adherence in Portugal
CPS-020 - Impact of the FIT® Training Program on Professional Development and Financial Sustainability of Portuguese Pharmacies
CPS-021 - Patient Reported Outcomes (PROs) and Experience Measures (PREMs) as Indicators of Effectiveness and Satisfaction in Pharmaceutical Interventions in Community Pharmacy
CPS-022 - Use of a digital platform to facilitate the implementation of observational studies and clinical trials in community pharmacy
CPS-023 - Gastrointestinal adverse events associated with over-the-counter ibuprofen: A narrative literature review
CPS-025 - Assessing medicine availability: A pilot study in Lithuania
CPS-026 - Barriers and opportunities in E-Pharmacy adoption: A cross-sectional study in Lithuania
CPS-027 - Developing a yearly national skills enhancement initiative on OTCs in Norwegian pharmacies
CPS-028 - Evaluating the impact of Independent Prescriber (IP) pharmacists in community pharmacy: Insights from the IP pathfinder programme at Bloxwich Pharmacy
CPS-029 - Best practices for community pharmacists in nursing homes: The case of the Brittany region (France)
CPS-030 - Echoes and insertion of the pharmaceutical practice into artificial intelligence
CPS-031 - Accompanying loneliness in rural areas: New role for community pharmacy
CPS-032 - Therapeutic adherence service through personalised dosing system (PDS), a tool in the fight against rural depopulation
CPS-033 - Regulation of the role of the pharmacist in prescribing vaccines in Brazil
CPS-034 - Assessing the impact of pharmacist led evaluation and intervention using the asthma impairment and risk questionnaire in patients with uncontrolled asthma
CPS-035 - Pharmacist provided care in community pharmacies in Washington State
CPS-036 - Pharmacy-based screening and adherence monitoring for Familial hypercholesterolemia in offspring using parental dyslipidaemia as a predictive factor: A pilot study
CPS-037 - Pharmacists' role in maternal and child health: Comparing pharmacists’ support for breastfeeding and safe medication use in Serbia and Croatia
CPS-038 - Interprofessional collaboration competency development in community pharmacy
CPS-039 - STAND BY ME: A framework for community pharmacists to intervene in substance misuse patients
CPS-040 - Addressing social determinants of health in rural community pharmacies through social work integration
CPS-041 - Factors impacting the primary care pharmacist scope of practice in Australia: Reflections of a national conversation
CPS-042 - Pharmaceutical intervention in promoting adherence to therapy through the implementation of an individualized medication preparation service that follows the patient's journey
CPS-043 - Evaluation of the impact of pharmaceutical intervention in the detection and monitoring of Chronic Venous Disease
CPS-044 - Urinary Tract Infection: the role of pharmacy in early detection and public health promotion
CPS-045 - Evaluation of pharmaceutical intervention in the detection and monitoring of allergic disease, assessing the impact the disease has on users' quality of life
CPS-046 - Impact of pharmaceutical intervention on adherence to therapy for asthma pathology, through teaching the correct inhalation technique
CPS-047 - Impact of point-of-care tests for group A Streptococcus infection on screening and accessibility to healthcare in pharmacies in Portugal
CPS-048 - The role of the pharmacist in the detection, intervention, and motivation for the treatment of obesity
CPS-049 - Exploring medication refill patterns and factors influencing adherence of hypertensive patients through electronic prescription and dispensing data
CPS-050 - Community pharmacists as a key driver in benzodiazepine withdrawal using compound tapering schemes
CPS-051 - How does the introduction of prescribing services in community pharmacy affect the roles and practices of the pharmacy team? A scoping review
CPS-052 - Community pharmacists: Perspectives and challenges in adult vaccination
CPS-053 - Challenges of inhalation therapy: why inhalation technique services matter
CPS-054 - Evaluating cost burden & regulatory compliance for labelling in Indian nutraceutical supplements
CPS-055 - Psychological perspectives on follow-up practices among community pharmacists in Japan: A qualitative study
CPS-056 - Designing for integrity in robot-assisted medication counselling: Potential clients' views on the pharmacy environment and patient integrity in robot design
CPS-057 - In-use microbiological stability study of benzalkonium chloride stock solution for ophthalmic preparations
CPS-058 - A simulation-based approach to expanding pharmacist roles
CPS-059 - Community pharmacy review: what is being done, and what could be done better?
CPS-060 - Enhancing pharmacists’ role in sexual and reproductive health: A Canada-Japan comparison and educational initiative
CPS-061 - Exploring the relationship between self-reported SDOH and medication nonadherence amongst community pharmacy patients participating in a novel, digital health intervention.
CPS-062 - Empowering youth through education: A community-based approach to teen sexual risk prevention
CPS-063 - Illuminate360: A culturally responsive approach to mental health and substance abuse education
CPS-064 - A collaboration between pharmacy students and pharmaconomist students at Community Pharmacy
CPS-065 - Pharmacist-led metabolic health monitoring for people living with mental illness: The patient and pharmacist experience
CPS-066 - Enhancing pharmacy employees' competence in injection pen administration to improve diabetes management and patient safety
CPS-067 - Communication with other healthcare professionals regarding dose dispensing
CPS-068 - Facilitating pharmacist patient communication and assisting with identification of medication therapy problems using a novel digital health intervention
CPS-069 - Personal in a limited timeframe – person-centredness during counselling on non-prescription products
CPS-070 - Investigation of the involvement and advisory role of pharmacists in patient pharmacotherapy management, a cross sectional study in Corinthia, Greece
CPS-071 - Impact of the introduction of Generic Apixaban and Rivaroxaban: Case-study of a pharmacy in a suburban area of Lisbon, Portugal
CPS-072 - Evaluating the role of targeted communication during the vaccination season in a suburban pharmacy in the Lisbon metropolitan area (Portugal)
CPS-073 - Development of the one-stop smoking cessation service by community pharmacists under the universal health coverage scheme in Thailand
CPS-074 - Community Pharmacy-based common illness services under universal health coverage in Thailand: Outcomes and policy insights
CPS-075 - Illness perception in patients following the transfer of free-of-charge medicine dispensing from hospital to community pharmacy
CPS-076 - Spain’s map of pharmaceutical services
CPS-077 - The impact of annual price revision based on external reference pricing on medicines between 2012 and 2023, in Portugal
CPS-078 - Bringing vaccination closer to home: Environmental gains from expanding the 2023/24 Immunization to community pharmacies
CPS-079 - Preliminary results from the JunTOS research study: Improvement of pharmaceutical care in transplant patients
CPS-080 - Enhancing patient-centered counselling in Danish online pharmacies: Insights into preferences and the role of a counseling guide
CPS-081 - Valuing the profession and role of community pharmacists: Insights from a cross-sectional study in Portugal
CPS-082 - Enhancing professional collaboration among pharmacists in extended-hours pharmacies: Experiences from Glostrup Community Pharmacy
CPS-083 - Antimicrobial stewardship interventions involving community pharmacy teams: A scoping review
CPS-084 - Securing continuity of pharmaceutical care in the Netherlands
CPS-085 - The Evolution of Pharmaceutical Services in Brazil and the Role of Technological Platforms in the Standardisation, Compliance, Recording, and Traceability of Data
CPS-086 - Challenges and opportunities in community pharmacists’ role in chronic obstructive pulmonary disease management in Kosovo
CPS-087 - Realtime visualizing adherence in a public pharmacy setting: A call for insights
CPS-088 - Development of easier-to-swallow liquid capsules for tablet-averse individuals
CPS-089 - Factors associated with medication adherence among adults with asthma
CPS-090 - Can the local Pharmacy play an important role in helping to treat late effects after cancer treatment
CPS-091 - Empowering pharmacists for a digital future: Redefining patient care in retail pharmacy across India
CPS-092 - Pharmaceutical compounding in Portugal: A SWOT analysis of legal and regulatory frameworks
CPS-093 - Expanding the role of pharmacies in Portugal: New opportunities for intervention
CPS-094 - Forecasting pharmaceutical needs for 2023: A case study of CU Turgeau in the context of sustainable healthcare and collaborative innovation
CPS-095 - Is it necessary to attach additional substitution labels to medication?
CPS-096 - Social media for health: Creative strategies to overcome flu vaccine hesitancy across generations
CPS-097 - Advancing pharmacy through soft skills: A key to performance, collaboration, and transformation
CPS-098 - Optimizing communication workflow between community pharmacies and municipal institutions
CPS-099 - Vaccination services in the Norwegian deregulated pharmacy market
CPS-100 - The role of pharmacists in public pharmacies in managing pharmaceutical waste
CPS-101 - The impact of eczema and unintended consequences of its management: Opportunities for pharmacists
CPS-102 - Impact of pharmacist-led home medication management on patient adherence and healthcare communication
CPS-103 - Community pharmacist’s role in insomnia management
CPS-104 - Implementation of competency development for better handling of dose-dispensed medication at a local community pharmacy
CPS-105 - Enhancing outpatient medication safety through national medication safety reports: A case of biological medicines
CPS-106 - Evaluation of a newly developed elective course on interprofessional collaboration in pharmacy technician education
CPS-107 - Available evidence on formal recognition and implementation of advanced-level practices in community pharmacy: a scoping review
CPS-108 - The Danish network for community pharmacy practice research and development
CPS-109 - How to present the results of your research with a good poster?
CPS-110 - Study of the effectiveness of pharmaceutical intervention in improving therapeutic adherence in patients with asthma and COPD
CPS-111 - What is important for the patient in online and telephone counselling? A literature review
CPS-112 - Evaluating the effectiveness of acute migraine treatments in community pharmacies
CPS-113 - Trends in COVID-19 vaccinations administered in community-based pharmacies to children and adolescents in the United States: State-wide study
CPS-114 - Integrating patient experiences in continuing education for Danish pharmacy staff: benefits and insights
CPS-115 - Fun, engaging and effective: Transforming pharmacy staff training with microlearning
CPS-116 - Health and sustainability: The social impact assessment of the abem: programme
CPS-117 - Proximity dispensing of hospital medicines in Portugal: A step-by-step implementation and its potential environmental impact
CPS-118 - Valproate-containing medicines and additional risk minimization measures: Knowledge and attitudes of the community pharmacist
CPS-119 - Multidisciplinary clinical medication reviews in primary care: General practitioner, pharmacist, nurse and patient together improving patient’s therapeutic plan
CPS-120 - Analysing medication safety incidents in community pharmacies: Leveraging incident reporting data for healthcare operational improvements
CPS-121 - Developing a medication safety self-assessment tool for high-Alert medications in community pharmacies
CPS-122 - Community pharmacist-provided point-of-care testing for influenza and COVID-19: A systematic review
CPS-123 - Understanding the needs of obesity patients in Norwegian pharmacies
CPS-124 - Evaluating a CPD programme on asthma care for pharmacist guided by the competency-based education approach: A feasibility study
CPS-125 - A study of patient behavior in self-medication with Wegovy in pharmacy practice
CPS-126 - Retention of pharmacists in community pharmacies
CPS-127 - Development of job descriptions for employees at Dalgas Boulevard Pharmacy, detailed in relation to responsibilities, tasks, references, competencies, qualifications, and expectations
CPS-128 - Co-design and development of a community pharmacy-based Cardiovascular Disease (CVD) risk screening service in Saudi Arabia: A multi-stakeholders Nominal Group Technique (NGT) consensus method
CPS-129 - Paracetamol: Effect and compliance
CPS-130 - Dose dispensed medicine and medication adherence
CPS-131 - Development and implementation of digital pharmacy for primary care service in Thailand
CPS-132 - Development guideline pharmaceutical substitution in medicine shortage
CPS-133 - Healthcare collaboration in Denmark: Pharmaconomists from Glostrup Community Pharmacy supporting general practice
CPS-134 - Participation of pharmacists in the media in the Republic of Serbia - pharmacist as a journalist
CPS-135 - The medicines shortage reporting initiative (MedSRI): Preliminary results of an innovative approach to detect shortages on a European scale
CPS-136 - Women of colour rightfully feel quite vulnerable in the world. Tennessee minority women views about the human papillomavirus vaccine a qualitative study in the USA
CPS-137 - An explorative study on evaluating medication adherence in patients with different falling risks
CPS-138 - Modernising patient pathways: A global vision for community pharmacy to 2030
CPS-139 - Ask me about HPV- A pharmacy based educational initiative to empower Serbian pharmacies in promoting HPV vaccination
CPS-140 - Role of community pharmacists in allergic rhinitis management
CPS-141 - Cardiovascular risk assessments conducted in community pharmacy
CPS-142 - Exploratory study on community pharmacists’ wishes and needs to revise a national standard for pharmacy accreditation
CPS-143 - Extended pharmacist role in the eyes of pharmacists and physicians – results from national survey in Poland
CPS-144 - Development of an on-demand course in teaching for community pharmacy
CPS-145 - Mentalizing – a tool for improving customer satisfaction through emotional awareness and patient-centred communication
CPS-146 - A qualitative exploration of informal carers experiences in accessing and receiving support within community pharmacies
CPS-147 - Empowering pharmacists through population health management: The development of a barometer to strengthen primary care
CPS-148 - Pharmacists’ experiences with dispensing MS-2 step for medical termination of pregnancy in Australia
CPS-149 - Implementation of improved electronic medication data transfer in the kickstart: Almost ready to go live
CPS-150 - Better and more uniform medication monitoring in the Netherlands: Ready for the future!
CPS-151 - Pharmacist attitudes to community pharmacist access to digital patient records in Scotland
CPS-152 - A greener pharmacy toolkit to support a healthier planet
CPS-153 - Training for community pharmacists in Wales delivering the pharmacy independent prescribing service: The impact on self-perceived knowledge and skills
CPS-154 - Policy frameworks, theories or models underpinning health policy development: A systematic review
CPS-155 - A hybrid service model for sleep disorder management in pharmacies in Thailand
CPS-156 - nti-doping awareness among community pharmacists in Norway: A study using a simulated patient
CPS-157 - Pharmacists in Serbia in the fight against antibiotic resistance
CPS-158 - Systematic learning from medication safety incidents reported by Finnish community pharmacies
CPS-159 - Impact of Coenzyme Q10 as Adjuvant Therapy with Letrozole in Ovarian Stimulation for a Poor Ovarian Responder Undergoing IVF
CPS-160 - Promoting medication refills in patients with chronic diseases through Line smartphone application in Taiwan
CPS-161 - Standardized pharmaceutical services in the monitoring of chronic non-communicable diseases - the pharmacist as consultant for diabetes, asthma, and hypertension
CPS-162 - Constipation management and misconceptions: The essential role of pharmacists in patient education
CPS-163 - Identifying pharmacy services for healthcare professionals in Funen's nursing homes and home care facilities to optimize medication management.
CPS-164 - Development and testing of vitamin D measurement at the pharmacy
CPS-165 - Vaccine prescribing patterns at three (3) Canadian community pharmacy-locations in Vancouver, BC
CPS-166 - The risks and benefits associated with the self-selection of medications: A systematic review
CPS-167 - Exploring community pharmacists’ perceptions of the accessibility and rational use of innovative drugs in China under dual-channel policy: A qualitative study
CPS-168 - Strategies for professional pharmaceutical impact on Alzheimer's disease
CPS-169 - Exploring pharmacy professionals’ knowledge, perceptions, and practices related to climate change adaptation: A focus on wildfire smoke and extreme heat
CPS-170 - The role of community pharmacy in preventing cardiovascular disease in minority ethnic groups
CPS-171 - Independent prescribing in community pharmacy; what works for whom, why and in what circumstances (INTEGRATE): A realist review
CPS-172 - Assessing competencies in medication risk management among community pharmacists
CPS-173 - Pharmacist-led point-of-care testing services
CPS-174 - Community pharmacist guided cancer patient care at home
CPS-175 - A pharmacist's role in guiding paediatric patients with type 1 diabetes mellitus through the transition to adult care
CPS-176 - Prescription renewal in Danish community pharmacies
CPS-177 - Community pharmacists’ knowledge and role in immunisation in Japan: A survey on status areas for improvement
CPS-178 - Will training enhance antimicrobial stewardship implementation in community pharmacy? Bridging gap through a CPD Program
CPS-179 - Uptake and results of the National Health Service England community pharmacy hypertension case-finding service
CPS-180 - Development of a retail electronic prescription triage algorithm to reduce patient wait times and unclaimed prescriptions
CPS-181 - The Portuguese Pharmacies’ Proximity Program – “Every Pharmacies Matter” Program (Programa Todas as Farmácias Contam 2024)
CPS-182 - Implementing “SMIL” to strengthen the shared core task in a community pharmacy
CPS-183 - The creation of a vulnerability assessment for community pharmacies to improve their resilience to extreme weather and other disasters
CPS-184 - Transforming maternal and child health: The untapped potential of community pharmacists
CPS-185 - Optimizing pharmacy-clinic collaboration: The role of pharmacists in a chain pharmacy setting
CPS-186 - Managing allergic Rhinitis with non-sedating antihistamines in the community pharmacy
CPS-187 - Exploring the impact of delivering essential phospholipids as self-care on patient care pathway related greenhouse gas emissions in the Philippines
CPS-188 - Integrated community-based approaches to Hepatitis A & B awareness and prevention in Nigeria
CPS-189 - A mixed-methods evaluation of an education programme on mentalisation for community pharmacy workforce in Denmark to promote patient-centred counselling
SEC - Health & Medicines Information
HMS-001 - Rare diseases and therapeutic strategies
HMS-002 - Analysis of pharmacists' perception regarding the services of the medicines information center of the Portuguese pharmaceutical society
HMS-003 - Mechanisms underlying heatwave or high-temperature-induced headaches and migraines
HMS-004 - Development of a social mobilisation project for pharmacists to improve health population
HMS-005 - Enhancing health literacy in older adults: Development and impact assessment of the Healthy Generation Senior project
HMS-006 - A comparative analysis of e-label regulation status between Republic of Korea and Japan
HMS-007 - Consolidating a cluster formulary for enhanced patient care and resource accessibility
HMS-008 - Farmalibras: Facilitating pharmaceutical care for deaf sign language users in Brazil
HMS-009 - Development of educational videos on inhaler device use
HMS-010 - Workplace health literacy in Ohio: A comparison of 2013 and 2021
HMS-011 - Medicine regimens for people with diabetes living in residential aged care: A longitudinal study using routinely collected data in residential aged care facilities
HMS-012 - Healthcare utilisation for prescription medications: A descriptive study using a 10% random sample of pharmaceutical benefits scheme claims data (2013–2023)
HMS-013 - Development of an online vaccination training course for pharmacy professionals in Finland
HMS-014 - The hidden side of COVID-19: How much we have contributed to the spread of C. difficile infection through treatment?
HMS-015 - Strategies to improve health literacy among teachers, parents and students: A documentary analysis of 50 school medicine policies in England
HMS-016 - An exploration of physicians’ knowledge and perception about the use of medical cannabis in UAE: A qualitative study
HMS-017 - Comparison of epilepsy knowledge, awareness, and attitudes in Lebanon: General population versus pharmacy students
HMS-018 - Enhanced performance in patient comprehension: Evaluation of the effectiveness of icons, text, and combined formats for medication instruction
HMS-019 - Enhancing treatment compliance in dysphagic patients: The role of specialized oral drug formulations across age groups
HMS-020 - Association between chemotherapy-induced peripheral neuropathy and functional bowel disorders in cancer patients undergoing oxaliplatin-based chemotherapy: Evidence from real world data analysis
HMS-021 - Attitudes towards electronic package insert leaflets among medication users in Denmark
HMS-022 - Media coverage of medicines entering the market in Finland
HMS-023 - Measles infection following MMR vaccination: A case report and the national compensation process in Taiwan
HMS-024 - Quality and satisfaction: A comprehensive evaluation of drug information services in Jordan
HMS-025 - Evolution of Warfarin
HMS-026 - Pharmacists + AI = True: Enhancing health communication in a Norwegian online pharmacy through the application of artificial intelligence (AI)
HMS-027 - Drug and Substance use. A perspective from Zimbabwe and, a call for action for pharmacists and pharmaceutical scientists in this global health threat.
HMS-028 - Digital health interventions delivered by healthcare professionals and the impact on patient self-care: A systematic review in progress
HMS-029 - Pharmacist and consumer perspectives on the effectiveness and over-the-counter availability of pseudoephedrine
HMS-030 - Bridging the digital health divide: Developing a digital health quotient (DHQ) framework for enhanced adoption and impact
HMS-031 - Exposure of professional pharmacists to workplace stress factors in Bosnia and Herzegovina
HMS-032 - Artificial intelligence: Transforming healthcare and life sciences in India
HMS-033 - Public perception survey of Singapore’s Know Your Meds series
HMS-034 - areness and knowledge of sexually transmitted diseases among secondary school adolescents in Bayelsa State, South- Southern Nigeria
HMS-035 - Digital Health Literacy investigation among digital consumers and patients
HMS-036 - Assessing the efficacy of traditional Chinese medicine in treating uremic pruritus: A systematic review and meta-analysis
HMS-037 - How can we do pharmacovigilance better? Indonesians’ voices on the pharmacist’s role in managing side-effect experience: A qualitative study
HMS-038 - Longitudinal linkage of paracetamol poisoning hospital admissions in NSW, Australia
HMS-039 - Personalized drug dosing and pharmacotherapeutic recommendations for obese and post-bariatric surgery patients
HMS-040 - Impact of cephalosporins on outcomes of warfarin therapy: A multicentre retrospective cohort study
HMS-041 - Adherence patterns and influencing factors in inhaler use among COPD and asthma patients in Albania
HMS-042 - Exploring the influence of social media on eating behaviours in childhood and adolescence: A cross-sectional survey of young adult and parent perspectives
HMS-043 - Pharmacoeconomics of stem cell therapies for diabetes and neurodegenerative diseases: The role of clinical pharmacists in cost optimization
HMS-044 - Multiple disciplinary engagement on artificial intelligence in healthcare
HMS-045 - Estrogen suppressant prescription negatively associated with topical steroid use and itch in females: Evidence from analyses of pharmacy claims data and adverse drug reaction database
HMS-046 - Applying information and communication technologies to tackle public health threats: Creation of a mobile application for mapping venomous animal species
HMS-047 - Mobile App in improvement of medication adherence in patient with chronic diseases: an updated systematic review and meta-analysis
HMS-048 - For the development of international interoperability of pharmaceutical information- In the Case of Japan -
HMS-049 - Prevalence and risk factors of use of potentially inappropriate medications in older outpatients using Japanese health insurance claims database
HMS-050 - Does the risk of myocardial infarction, stroke and thrombosis change in people with menstrual and uterine disorders treated with analgesics, hormonal contraceptives and tranexamic acid?
HMS-051 - Digital tool in primary health care; QR code for suspected adverse drug reaction reporting
HMS-052 - Safer doesn’t mean safe – the scale of risk for alternatives to smoking
HMS-053 - Harnessing generative AI for global medical insights
HMS-054 - A smartphone-based decision support app for total parenteral nutrition prescription via WeChat mini-program
HMS-055 - Interactions between low-grade chronic inflammation with medication intake, health status, and socio-economic factors on the aging populations on the developing country
SEC - Hospital Pharmacy
HPS-001 - Retrospective analysis of infusion-related reactions following parenteral administration of cytostatic drugs in a tertiary cancer center
HPS-002 - Analysis and management of drug shortages in a regional Hospital (2021-2024)
HPS-003 - Gastroesophageal Reflux Disease (GERD): An ayurvedic overview of Indian system of medicine & role of hospital pharmacist
HPS-004 - Development and implementation of an emergency department migrant prescription program
HPS-005 - Assessing the effect of pharmacist counselling on adherence to antihypertensive medication therapy at a quaternary hospital in Ghana
HPS-006 - The evolving role of pharmacists in patient care: A retrospective review at a quaternary teaching hospital in Ghana
HPS-007 - Pharmacy workforce sustainability in the United States: Assessing hospital pharmacists’ well-being and work environments using the NIOSH WellBQ
HPS-008 - Pharmaceutical care for a tumor patient with interstitial lung disease due to EGFR-TKI and AIDS opportunistic infection
HPS-009 - Reducing the incidence of multidrug-resistant pneumonia in neurosurgical patients: Pharmaceutical prevention and control based on rational use of antibacterial drugs requires more attention
HPS-010 - Risk factors associated with inequalities in antibiotic-resistant bloodstream infections: A rapid umbrella review with considerations of opportunities for pharmacy professionals
HPS-011 - TOP Hospital Pharmacy - The excellence of hospitals: Applying key performance indicators to assess hospital pharmacies performance in Portugal
HPS-012 - Reasons for hospitalization among patients with type 2 Diabetes mellitus in a primary care hospital in Ghana
HPS-013 - Initial assessment of a newly implemented medication administration dashboard at St. Bartholomew Hospital in London, England
HPS-014 - Polypharmacy patterns: The role of clinical pharmacist among elderly cardiac patients at a university hospital in Riyadh, Saudi Arabia
HPS-015 - Assessment of a patient safety culture: A nationwide cross-sectionalstudy comparing public and private hospitals in Kuwait
HPS-016 - Co-morbidities among people living with HIV receiving antiretroviral therapy in a Ghanaian teaching hospital
HPS-017 - Stability of daptomycin in icodextrin-based peritoneal dialysis solution
HPS-018 - Understanding and addressing challenges in provision of emergency medications for patient transport to off-site healthcare institutions. A review to improve efficiency and quality of care.
HPS-019 - Validation of an enhanced controlled drug management system linked to an operating room anaesthesia management system using two-dimensional codes
HPS-020 - Incorporation of artificial intelligence in oncohematology clinical practice
HPS-021 - Evaluation of meropenem utilization at a quaternary care hospital in Ghana: A retrospective review
HPS-022 - Implementation of continuous glucose monitor system at hospital discharge in diabetes patients
HPS-023 - Opportunities for oncology pharmacists in the field of oral cancer therapy
HPS-024 - The impact of pharmacist practitioner-led hospital placements: The hospital perspective
HPS-025 - The impact of pharmacist practitioners on hospital placements for pharmacy students
HPS-026 - Examining the implementation status of pharmacy services outlined in "Position paper on critical care pharmacists in Japan": A web-based nationwide questionnaire survey
HPS-027 - Evaluating the impact of a pharmacy administration and leadership short course targeting multidisciplinary pharmacy leaders in Ethiopia
HPS-028 - Comparison of the FIP Basel Statements on the future of hospital pharmacy practice and global pharmacy school accreditation standards
HPS-029 - An intervention to reduce anticholinergic prescribing in hospitalised older adults
HPS-030 - Comparative study of pharmaceutical missions in healthcare facilities in Quebec and in France
HPS-031 - Comparative study of clinical pharmacy activities in healthcare facilities in Quebec and in France
HPS-032 - Development and evolution of a clinical pharmacist-managed clinic at an academic medical center in the United States as a component of anticoagulation stewardship
HPS-033 - Strategies to decrease the environmental impact of inhaled anaesthetics
HPS-034 - Real-world effectiveness of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in a specialised tertiary hospital in Kuwait: A retrospective cohort study
HPS-035 - Characterising the current practices of science popularisation by hospital pharmacists: A nationwide cross-sectional survey in China
HPS-036 - Pharmacy and oncology clinic hazardous neoplastic drugs surface contamination testing in Canadian hospitals
HPS-037 - Tacrolimus Syrup Reformulation to increase stability and suitability in pediatric patients
HPS-038 - Assessing antimicrobial stewardship in selected private healthcare facilities in Lagos, Nigeria
HPS-039 - Acute pancreatitis management in a clinical emergency hospital: Compliance with therapeutic guidelines and hospital policy
HPS-040 - Effect of a hospital drug formulary on antibiotic consumption and patient outcome in Japanese university hospital: An interrupted time-series analysis
HPS-041 - Knowledge Attitude and Practice of Pharmacists in Transition of Care Services in Tertiary Healthcare Settings in Lagos State Nigeria
HPS-042 - Drug-drug interactions in the treatment of chronic comorbidities and effects on the patient management: Type 2 Diabetes and Chronic Coronary Syndromes
HPS-044 - The impact of undisclosed foreign medications on patient care in the United States
HPS-045 - Physicochemical and Microbiological Stability of Compounded Rifaximin Oral Suspensions in PCCA Base, SuspendIt®
HPS-046 - The influence of gender and age on orthopaedic patients’ comprehension of injury-related information
HPS-047 - Knowledge on antimicrobial resistance and stewardship in two health facilities in Ghana
HPS-048 - A study on the impact of Dapagliflozin on HbA1c levels and proteinuria in patients with type 2 diabetes
HPS-049 - Suspected Daptomycin-Induced Eosinophilia
HPS-050 - Management strategies for medications in rural mobile healthcare: A case study of Zhuoxi Township, Taiwan
HPS-051 - A formative evaluation of the implementation of a medication-centred discharge service in rural and regional Australia: A qualitative study of clinicians and patients
HPS-052 - Five-Year analysis of drug-induced liver injury in a Chinese Tertiary Hospital: Clinical characteristics and prognostic insights
HPS-053 - Social determinants of health and access to medicines and their association with antidiabetic medication adherence at a teaching hospital in Ghana
HPS-054 - Antidiabetic drug utilization at a teaching hospital in a resource-limited setting
HPS-055 - Knowledge, attitude and practices toward stroke disease among diabetic and hypertensive patients seen at St. Martin’s Catholic Hospital, Agroyesum, in Ghana
HPS-056 - A comprehensive approach to SGLT2 inhibitors safety: Results from a two-year quality initiative on prescription screening and patient education
HPS-057 - Optimisation of medical inventory management system: A five-year analysis and implementation of auto-refill System (2020-2024)
HPS-058 - Medication error interventions in health facilities: A qualitative study of healthcare providers’ experiences, strategies and challenges in Eastern region of Ghana
HPS-060 - Combination therapy of cabergoline and metformin in Polycystic Ovarian Syndrome with hyperprolactinemia: Evidence based
HPS-061 - Pharmacoepidemiology of anti-HER2 ADC induced interstitial lung disease: Real-world data analysis based on the FAERS database
HPS-062 - Efficacy and safety analysis between first-line immunotherapy and chemotherapy in patients with KRAS mutant non-small cell lung cancer (NSCLC)
HPS-063 - Hypocalcemia incidence in denosumab use: A district hospital analysis
HPS-064 - Exploring the correlation between Chinese herbal medicine and idiopathic mesenteric phlebosclerosis: A systematic review and integration into an adverse drug reaction alert system
HPS-065 - Evaluation of Brexpiprazole use in elderly patients at a psychiatric hospital
HPS-066 - Patient-centered hospital pharmacy: Opinion survey and opportunities for improvement
HPS-067 - Assessment of chemotherapy-induced nausea and vomiting (CINV) management strategies in a resource-constrained oncology setting
HPS-068 - Safety of JAK and TNF inhibitors in rheumatoid arthritis: A systematic review and meta-analysis of real-world evidence
HPS-069 - Combined diazoxide and octreotide therapy for congenital hyperinsulinemia: A case report
HPS-070 - Effectiveness of pharmaceutical care for outpatients with chronic kidney disease in a regional teaching hospital in Taiwan: A retrospective study
HPS-071 - Evaluation of a transitions of care stewardship pharmacist in facilitating post-discharge medication reviews: A qualitative study of pharmacists
HPS-072 - Enabling direct medication error reporting from hospital pharmacists to the Drug Commission of German Pharmacists via a technical interface: DokuPIK
HPS-073 - Introducing inpatient holistic pharmacy services for advanced pharmacy practice experience student education in one of medical center in southern Taiwan
HPS-074 - Improve medication administration safety for inpatient with CLMA
HPS-075 - Case report on Congenital Syphilis: Diagnosis, treatment, and outcomes
HPS-076 - Efficacy and safety of co-administration of albumin and diuretics compared to diuretics therapy in patients with Edema: A systematic review and meta-analysis
HPS-077 - Pharmacist-led antimicrobial stewardship programme in two tertiary hospitals in Malawi
HPS-078 - Improving medication safety through barcode scanning in Southern Taiwan regional hospital
HPS-079 - Infectious diseases stewardship program (IDSP) implementation in a Greek tertiary ospital
HPS-080 - Impact of a clinical decision support system on optimizing guideline-directed medication prescribing in heart failure
HPS-081 - Impact of pharmacist intervention on Vancomycin Therapy: A retrospective analysis from 2020 to 2023
HPS-082 - Enhancing chemotherapy drug compounding safety and efficiency: An AR and AI-based monitoring system for pharmacists
HPS-083 - Enhancing chemotherapy drug compounding safety: An AR and AI-Based monitoring system for pharmacists
HPS-084 - Logistic chain between Denmark and Greenland for medical transport
HPS-085 - From vision to reality: Implementing a robotic pharmacy for comprehensive hospital integration
HPS-086 - Predicting the unpredictable: Challenges in forecasting medicine demand in Sri Lanka
HPS-087 - Improving vaccination workflow efficiency and patient experience with refrigerated automated dispensing cabinets
HPS-088 - Use of proton pump inhibitors during the first year of life and late complications
HPS-089 - Minimum clinically important differences of functional pain tools: A systematic review
HPS-090 - Prognostic factors and survival analysis in Acute Myeloid Leukemia (AML) patients: A retrospective study from 2016 to 2024
HPS-091 - Unveiling job satisfaction among state hospital pharmacists: Insights from selected teaching hospitals in Colombo District, Sri Lanka: A study protocol
HPS-092 - Creating a waste data dashboard
HPS-093 - National recommendations for Y-site compatibility in handbook Parenteralia
HPS-094 - Real-world impact of finerenone on renal function in Type 2 Diabetes-Related Chronic Kidney Disease
HPS-095 - A step towards safety: Enhancing heparin infusion protocol compliance through pharmacist-led interventions
HPS-096 - Self-medication and contributing factors among pregnant women attending antenatal clinic in a regional hospital in Ghana
HPS-097 - A comparative documentary analysis of antifungal policies from NHS trusts participating in BioDrive Antifungal Stewardship
HPS-098 - Association between proton pump inhibitor use and renal function decline in chronic kidney disease: A Retrospective Analysis using data from a regional hospital in Taiwan
HPS-099 - Low monitoring rate of hematologic adverse effects in sulfasalazine users: A retrospective study in a Northern Taiwan medical center
HPS-100 - Pharmacist-led medication reviews in dementia care: addressing drug-related problems in Taiwan
HPS-101 - Evaluation of a Hub and Spoke Model to enhance capacities of healthcare professionals in the Volta Region of Ghana in the practice of Antimicrobial Stewardship
HPS-102 - Case report: Off-label use of magnesium sulfate for cerebral palsy prevention in preterm infants
HPS-103 - Off-label use of imiquimod for the treatment of oral leukoplakia: A case report
HPS-104 - Off-label use of Indomethacin and Nifedipine for tocolysis in acute preterm Labor: A case report
HPS-105 - Prophylaxis strategies for venous thromboembolism in patients undergoing total hip or knee arthroplasty in Southern Taiwan
HPS-106 - Enhancing type 2 diabetes management using pharmacist interventions
HPS-107 - The efficacy of Neurokinin-1 receptor antagonists in chronic pruritus: a systematic review and meta-analysis
HPS-108 - Readmission rates for hospital-associated thrombosis following TKR and THR: A comparison of Aspirin and Enoxaparin
HPS-109 - Evaluation of advanced hospital pharmacy practice and specialisation in a Nigerian tertiary health institution: Trends, challenges, and solutions
HPS-110 - You think you’re the only sick person? Others are sick too.’ From bureaucracy to bedside: Breast cancer patients’ experiences with special approval medicines in Malaysia
HPS-111 - Development and evaluation of a novel antibiotic point prevalence survey method in primary healthcare (APC-PPS); Results from the Korle bu Polyclinic
HPS-112 - Patterns of antimicrobial use in 4 major departments in Ghana’s largest teaching hospital during two global point prevalence surveys in 2023 and 2024
HPS-113 - Enhancing pharmacy students’ academic performance and empathy through an exploratory learning approach
HPS-114 - Efficacy and safety of colchicine on adverse cardiovascular outcomes in patients with myocardial infarction: A systematic review
HPS-115 - Real-World venetoclax dosage in patients with Acute Myeloid Leukemia receiving moderate or strong CYP3A4 inhibitors
HPS-116 - Dose-dependent effects of amantadine on neurological recovery in ICU patients with severe neurological impairment: A retrospective study
HPS-117 - Real-world evidence of SGLT2 Inhibitors in slowing kidney disease progression in diabetic nephropathy: A retrospective cohort study
HPS-118 - Analysis of abnormal drug dispensing events in a medical center
HPS-119 - Development of entrustable professional activities in a clinical pharmaceutical care training program for hospital pharmacists
HPS-120 - Evaluation of the use of progesterone drugs to prevent premature birth
HPS-121 - Drug use assessment of naldemedine
HPS-122 - Assessment of drug use of oseltamivir phosphate for oral suspension powder
HPS-123 - Evaluation of drug use in the treatment of encapsulating peritoneal sclerosis by tamoxifen
HPS-124 - Analysis of rationality of drug prescription of dihydroergotamine
HPS-125 - Local antibiogram development for enhanced diagnosis and treatment of urinary tract infections: A case study from a quaternary hospital in Ghana
HPS-126 - Assessment of antimicrobial prescribing patterns: A longitudinal point prevalence survey analysis in a quaternary healthcare facility in Ghana
HPS-127 - The role of the pharmacist in preventing errors at transitions of care
HPS-128 - Transition from manual dispensing to dose packed medicine: Maximizing time savings and optimizing workflows in nursing homes
HPS-129 - The role of outpatient pharmacists in tuberculosis treatment tracking: A case report
HPS-130 - Effect of admission medication reconciliation program developed by multidisciplinary team at Rajavithi Hospital
HPS-131 - From dispensing to direct patient care: Hospital pharmacists’ perspectives on clinical pharmacy transition in Sri Lanka: A study protocol
HPS-132 - Impact of clinical pharmacist-led interventions on preventing medication errors in surgical intensive care unit patients
HPS-133 - The efficacy and safety of eliminating 5-Fluorouracil Bolus versus keeping 5-Fluorouracil Bolus from FOLFOX and FOLFIRI Regimen: A retrospective study
HPS-134 - Establishing and evaluating a pharmacist-led program for anticholinergic deprescribing in dementia patients: A pilot study
HPS-135 - Improvement of impaired consciousness in a traumatic brain injury patient treated with Cerebrolysin: A case report
HPS-136 - Innovative standardized medication distribution system in provincial correctional facilities in Alberta, Canada
HPS-137 - The effectiveness of establishing a guidance for the off-label use of atropine 1% eye drop in patients with clozapine-induced sialorrhea
HPS-138 - A network meta-analysis of antipsychotic agents in the treatment of delirium in clinical ill patients
HPS-139 - The impact of Midodrine on the time to discontinue intravenous Vasopressor use in ICU patients
HPS-140 - Improving medication safety: Analysis and outcomes of interventions for medication-related problems in hospitalized patients
HPS-141 - Development of a clinical pharmaceutical service promoting active ageing
HPS-142 - Pembrolizumab related Early-Onset Pancytopenia: A case report and literature review
HPS-143 - Effectiveness and safety of idursulfase enzyme replacement therapy in infants diagnosed with Mucopolysaccharidosis II through newborn screening: A case series
HPS-144 - Real-world experience of Avalglucosidase Alfa in infantile-Onset Pompe Disease: A case series study
HPS-145 - Prescription patterns and effectiveness of Sacituzumab Govitecan in the real-world treatment of advanced breast cancer among Asian populations
HPS-146 - Comparison of cancer risks associated with JAK inhibitor and TNF inhibitor treatment in patients with Rheumatoid Arthritis: A systematic review and meta-analysis of real-world cohort studies
HPS-147 - Enhancing consultant pharmacists-teaching competencies in evidence-based medicine using the PDCA method
HPS-148 - Fluconazole as an alternative in Cushing’s syndrome: A 10-year retrospective cohort
HPS-149 - Efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors for hepatocellular carcinoma: A systematic review and meta-analysis
HPS-150 - Evaluation and analysis of potentially inappropriate medication use among frail older inpatients based on the STOPPFrail criteria: a preliminary report
HPS-151 - Transforming small pharmacies with automated dispensing cabinets: Impact, challenges, and efficiency gains
HPS-152 - The benefit of pharmacist clinic intervention for diabetic patients
HPS-153 - Enhancing patient experience and satisfaction through pharmacist-led discharge medication counseling at a tertiary hospital in Indonesia
HPS-154 - Utilizing clinical decision support system for outpatient prescription review: Clinical pharmacist’s experience at a medical center in Southern Taiwan
HPS-155 - An analysis of relation between vancomycin area under the curve and trough concentrations in specific populations in Taiwan
HPS-156 - Retrospective analysis of emergency department cases with metformin-related lactic acidosis
HPS-157 - The impact of Nintedanib related adverse effects on clinical outcomes in patients with idiopathic pulmonary fibrosis: An analysis of preliminary
HPS-158 - Optimizing processes of returning unused medications of inpatients to pharmacy
HPS-159 - The effectiveness of computerized physician order entry and clinical decision support systems in mitigating inpatient intravenous medication flow rate errors: A five-year study
HPS-160 - A 5-year analysis of high-alert medication error harm frequency and severity in a Taiwan university hospital
HPS-161 - Impact of optimized computerized physician order entry on reducing physician prescription wrong dose errors: A five-year analysis
HPS-162 - Risk of ocular adverse events with Trastuzumab: A case report
HPS-163 - One system, one team: Enhancing medication safety and efficiency through hospital-wide integration of smart dispensing and infusion technologies
HPS-164 - Substandard and falsified antimicrobial medicines: assessment of quality of various antibiotics procured in four hospitals in South East Nigeria
HPS-165 - The physical compatibility of the central nervous system drug Ginkgo biloba extract with frequently drugs used in the neurological intensive care unit
HPS-166 - Opportunities for improving antibiotic use: Assessment of the management of pyelonephritis in adult women and concordance with Infectious Disease Society of America (IDSA) Guidelines
HPS-167 - Improving pharmacy workflow to reduce medication wait times and enhance patient experience: A quality initiative from Taiwan
HPS-169 - Pharmacists’ contributions towards antimicrobial therapy in an intensive care setting
HPS-170 - Evaluation of Oxytocin use during labour
HPS-171 - Relationship between genotype and/or phage ORF type of ESBL-producing Escherichia coli and fluoroquinolones resistance in hospitals at big city area and regional city
HPS-172 - Pharmacotherapy for hospitalized patients with Covid-19: A drug utilization study in a Covid-19 dedicated unit of a tertiary hospital in Ghana
HPS-173 - Evaluation of steady-state exposure and early cardiotoxicity in Asian patients with HER2-positive breast cancer treated with trastuzumab
HPS-176 - Monitoring and analysis of serum voriconazole concentration in adults with pulmonary aspergillosis
HPS-177 - Study on the development of chronic disease drug management system during the COVID-19 situation by multidisciplinary professionals, Yang Chum Noi District Health Service Network
HPS-178 - Utilization of AI in providing real-time alerts for pharmacists' interventions to improve patient safety and outcomes related to patient hospital falls and related harms
HPS-179 - Medication changes after palliative care transition in elderly end-stage cancer patients: Focus on palliative care essential medicines and potentially inappropriate medicines
HPS-180 - Global patterns in antimicrobial stewardship implementation, antibiotic resistance, and health expenditure
HPS-181 - Evaluation of the applicability of open access vancomycin web calculators in critically ill patients: A comparison of predicted and measured values
HPS-182 - Investigating the suspected drugs associated with drug-induced liver injury and evaluating the use of hepatoprotective drug use as a treatment: a single-centre retrospective study
HPS-183 - Comparing efficacy of clomiphene citrate and letrozole for ovulation induction in infertile women: Hospital-Based Cohort Study
HPS-184 - The safety of traditional Chinese medicine for patients with G6PD deficiency
HPS-185 - An evaluation of pharmacist-led interventions in long-term care facilities by studying drug related problems
HPS-186 - Prognostic analysis of survival in patients with advanced non-small cell lung cancer treated with antineoplastic agents
HPS-187 - Pre- and post- intervention analysis for efficiency of hospital committees in implementing measures to control antimicrobial resistance
HPS-188 - Precipitating factors of look-alike medicines in public supply of Pakistan
HPS-189 - Prescribing patterns of vancomycin for inpatients in a super-tertiary care hospital in Thailand
HPS-190 - Real-world evaluation of administration-site reactions and patient preference regarding subcutaneous trastuzumab in Chinese patients with early breast cancer
HPS-191 - Designing and implementing a new approach in multifactorial risk identification to improve patient prioritisation for pharmacists in Dr Gray's Hospital, Elgin
HPS-192 - Reducing interruptions to typists: Let the dispensers do-it-yourself
HPS-193 - Automating adverse drug reaction (ADR) report analysis for enhanced risk mitigation
HPS-194 - Reducing medication errors in pediatric emergency triage: The impact of standardized sodium bicarbonate guidelines
HPS-195 - Evaluating the rational use of albumin based on evidence and practice: A concurrent study
HPS-196 - Evaluating the need for an antifungal stewardship program to improve prescribing practices in a low-middle-income country
HPS-197 - Enhancing renal dose optimization strategies in hospitalized patients: A novel approach for increased medication safety and clinical outcomes
HPS-198 - Enhancing patient safety through standardized storage of high-alert medications in nursing units: A quality improvement initiative in a low-middle-income country
HPS-199 - Transforming electrolyte management in critical care unit: Evaluating the impact of Pharmacist-led interventions on prescribing practices in a tertiary care hospital
HPS-200 - Pharmaceutical care pathway for endocrine therapy of breast cancer
HPS-201 - Exploring nursing perspectives on automated dispensing cabinets: Advancing safety and efficiency in a tertiary hospital
HPS-202 - Comparative effectiveness of antibiotic strategies for stenotrophomonas maltophilia infections: A systematic review and network meta-analysis
HPS-203 - Patterns of antimicrobial consumption at the ola during Children’s Hospital in Freetown, Sierra Leone: A global point prevalence survey.
SEC - Industrial Pharmacy
IPS_001 - Development of a quantitative near-infrared spectroscopy method for Lisinopril analysis during the blending stage of tablet manufacturing
IPS_003 - Monitoring of solid-liquid systems during pharmaceutical processing using Electrical Resistance Tomography (ERT) as Process Analytical Technology (PAT)
IPS_004 - Quality control of radiopharmaceuticals: Case of Fluorodeoxyglucose (FDG)
IPS_005 - Excipient and process sustainability in the manufacture of oral solid dosage forms - Targeted literature review as complementary method to life cycle assessment
IPS-002 - Optimizing the pharmaceutical supply chain in Qatar’s primary healthcare centers: A data driven forecasting approach
IPS-006 - Impact of Soft Skills on Employee Performance in Saudi Pharmaceutical Industry
SEC - Military & Emergency Pharmacy
MEPS-001 - Coordination of pharmaceutical support in disaster-affected areas with increased regional imbalance of pharmacists in Japan
MEPS-002 - Review of an Emergency Medical Team (EMT) Type 2 Medicine Cache
MEPS-003 - Development and use of an automated electronic vaccination database for a volunteer deployable workforce
MEPS-004 - Prospect of 3D printing technology in emergency pharmacy
MEPS-005 - Expert consensus on emergency medicine supply for the national emergency and rescue medical alliance (NERMA)
MEPS-006 - Exploring the psychological impact of delivering care in war zones: Approach to mental illness management for deploying soldiers
MEPS-007 - Establishing an Antimicrobial Stewardship (AMS) governance framework at the 34 Military Hospital: The role of global point prevalence survey data and behaviour change interventions
MEPS-008 - Business continuity plans in hospital pharmacies: A Delphi study
MEPS-009 - The role of a military pharmacist in the World Motorsport Championships
MEPS-010 - Safety considerations in treating botulism with equine-derived antitoxins
MEPS-011 - Evaluation of the health information system in emergency medical response: Pharmaceutical management and BCP in field simulation
MEPS-012 - Strategies and challenges in valuing first-aid pharmaceuticals
MEPS-013 - Medicine kits for non-medical personnel
MEPS-014 - Sustainable practices in the maintenance of an emergency medical team medicine cache
MEPS-015 - Advancing global collaboration: Implementation of the virtual global symposium on the pandemic response and its impact on pharmacy education and practice
MEPS-016 - Ukrainian patients’ perspectives on advanced pharmaceutical services provided by polish Pharmacists: A cross-border support initiative
MEPS-017 - Pharmacists on the frontline: Enhancing disaster and epidemic preparedness in Asia
SEC - Social and Administrative Pharmacy
SAPS-001 - Stepping up impactful advocacy: Building partnerships with decision-makers through Thank Your Pharmacist Day
SAPS-002 - Ideation to implementation: driving better and broader adoption of a core medicines list for palliative care in community settings to enhance access to critical medicines
SAPS-003 - Understanding barriers and facilitators to HIV PrEP access, use and adherence in urban Indigenous peoples in Toronto
SAPS-004 - Pharmacists' perceptions on the telepharmaceutical services for users of the Brazilian Public Health System with asthma and chronic obstructive pulmonary disease (COPD)
SAPS-005 - Impact of telepharmaceutical Care on people with asthma in a public pharmacy in the state of Rio Grande do Sul: a feasibility study
SAPS-006 - Perception of healthcare providers in a quasi-government hospital on providing health services to men who have sex with men in Ghana
SAPS-008 - Educational needs to develop an educational intervention on the storage and disposal of unusable medicines in a primary school
SAPS-009 - Perspectives of the Asociación Farmacéutica Mexicana to 2030
SAPS-010 - Trends in syphilis treatments and the impact of intramuscular injectable benzathine penicillin G in Japan: A descriptive study from April 2016 to September 2023
SAPS-011 - Pharmacists and environmental responsibility: Towards a greener future
SAPS-012 - Evolution of pharmacist specialisation and board certification: a model for achieving FIP development goal 4
SAPS-013 - Knowledge and adherence to oral anticancer medicines among oncology patients: insights from the National Hospital, Galle, Sri Lanka
SAPS-014 - Drug shortages in Latin America: Impact and strategies from the pharmaceutical perspective
SAPS-015 - Development of a strategy and organizational culture related to citizen engagement
SAPS-016 - Emerging areas of the pharmaceutical profession
SAPS-017 - Investigating the accessibility of HIV Self-Tests from Australian community pharmacies: A simulated patient study
SAPS-018 - The cost-effectiveness analysis of maintaining disease remission in atopic dermatitis patients using Abrocitinib and Dupilumab: From the perspective of healthcare payers
SAPS-019 - Quality indicators for community pharmacy in Switzerland
SAPS-020 - Ensuring the safe use of herbal food supplements: Council of Europe guidance for healthcare professionals and consumers
SAPS-021 - Council of Europe’s guidelines to harmonize the medication review process in Europe
SAPS-022 - Systematic review of mental health in HIV/AIDS care: Evaluating pathophysiology, standards of care, and research gaps
SAPS-023 - National drug formulary: Evaluating the usability of the national drug reference base
SAPS-024 - A landscape analysis of respiratory health risks in a changing climate: Insights from a global social study
SAPS-025 - Psoriasis patients’ perceptions of biosimilars and associated factors
SAPS-026 - Association between sufficient medicines information and perceptions of biosimilars among psoriasis patients
SAPS-027 - Predicting prescription review skills performance using eye-tracking features: A regression analysis with advanced machine learning models
SAPS-028 - Association of social determinants of health with opioid misuse among individuals with common psychiatric conditions
SAPS-029 - Longevity: Establishing a policy framework for fostering healthy ageing through lifelong vaccination
SAPS-030 - Patterns of anti-hypertensive drug utilisation and adherence to hypertension treatment in Lokoja Nigeria
SAPS-031 - Assessment of medication management challenges and technology readiness among visually impaired persons: A cross-sectional survey using a validated IMPACT-VIP questionnaire
SAPS-032 - High-impact innovations: Pharmaceutical ecosystems for just sustainability
SAPS-033 - Understanding scope of practice expansion: Pharmacists experience with scope of practice expansions across Canada
SAPS-034 - Content validity and inter-rater reliability of a classification system for drug-related problems for community pharmacists in Japan
SAPS-035 - Pharmacist-led deprescribing interventions for older adults with polypharmacy: A large-scale study of community pharmacy practice in Japan
SAPS-036 - The outcomes of pharmacist-led pharmaceutical care within community pharmacies: An overview of systematic reviews
SAPS-037 - Metabolic monitoring for adults living with a serious mental illness on a second-generation antipsychotic agent: A scoping review
SAPS-038 - Optimizing the benefits and mitigating the adverse effects of international health worker migration: A qualitative analysis of stakeholder perspectives in Nigeria
SAPS-039 - The overview of orphan drug utilization in Taiwan in 2023
SAPS-040 - Waiting times to start treatment with medications for opioid use disorder among US Medicaid Recipients, 1999-2020
SAPS-041 - Chemotherapy access in a resource-limited setting: A cross-sectional analysis of availability and gaps at Malawi’s National Cancer Centre
SAPS-042 - Sustainable capacity building for antimicrobial stewardship (AMS): Training pharmacists and AMS team members as leads across referral and district hospitals in Malawi
SAPS-043 - An international review of medication-related health services in correctional settings: A bibliometric analysis comparing medication-related health services and pharmacy-specific research.
SAPS-044 - Early intervention to support healthy ageing and ongoing management of chronic conditions: integrating pharmacists into general practices in Australia
SAPS-045 - The integration of human narratives into pharmaceutical policy decision-making: Best practices of citizen engagement in the Western Pacific WHO region
SAPS-046 - Impact of an interprofessional preventive care–focused education programme on formerly incarcerated individuals’ trust in the health care system
SAPS-047 - Transforming health through performance, collaboration, and oncology pharmacy leadership
SAPS-048 - A study on factors influencing risk management among personnel at Yang Chum Noi Hospital, Sisaket province
SAPS-049 - Collection of patient-reported outcomes in the real-world setting: Insights from registries indexed in the heads of medicines agencies-European Medicines Agency catalogues of real-world data sources
SAPS-051 - Evaluating West African HIV/AIDS policies: Inclusion of pharmacists, men who have sex with men, and transgender individuals in national strategic plan development and implementation
SAPS-052 - Medicines accessibility through a reimbursement model in a national health service
SAPS-053 - Abortion medication availability in community pharmacies when mifepristone is regulated as a normally prescribed medication: a mystery caller study
SAPS-054 - Contraception prescribing among pharmacists in British Columbia: practices, attitudes, barriers and facilitators in the first year following scope expansion
SAPS-055 - Pill splitting for sustainability: Reducing waste and cost in healthcare
SAPS-056 - Bridging the gap to innovative therapies for pediatric rare diseases: The role of clinical trials
SAPS-057 - Systematic review of the efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
SAPS-058 - Assessing herbal ingredients in food supplements: Regulatory challenges and health risks
SAPS-059 - The Japanese version of the perceived service quality scale for community pharmacies: Scale development and validation
SAPS-060 - Challenges in medicinal packaging for older people: Insights from a rehabilitation setting
SAPS-061 - Digitalised monitoring of prescription patterns for reimbursed medicine
SAPS-062 - Caring for people who use drugs: A Global review of the evolving role of pharmacy professionals in harm reduction services
SAPS-063 - How can community pharmacy teams prevent prescription and over-the-counter opioid misuse? A qualitative study using the Capability, Opportunity, and Motivation Behaviour (COM-B) model
SAPS-064 - Development of pharmacists ethical code
SAPS-065 - Enhancing the capacity of community pharmacists for PrEP initiation in Baltimore and San Diego: an implementation mapping study
SAPS-066 - Enhancing pharmacist performance: Development of a capability framework to support Australia’s evolving healthcare needs
SAPS-067 - Pharmacist-led review of drug utilization of antipsychotic medications in a tertiary government hospital
SAPS-068 - Challenges and enablers impacting the implementation of South Africa's Central Chronic Medicines Dispensing and Distribution Program: A scoping review
SAPS-069 - Singapore’s pharmacy leadership development strategy
SAPS-070 - Building upon peer support with industry-specific stress management resources to support a sustainable Australian pharmacy workforce
SAPS-071 - Exploring Australia early career pharmacists' sources of stress and their coping strategies
SAPS-072 - Understanding First Peoples lived experience of pharmaceutical care during healthcare transitions: A grounded theory study
SAPS-073 - Best practices in citizen engagement for pharmaceutical policy: Insights from the WHO European Region and Scandinavian case studies
SAPS-074 - Medicine shortages in Sri Lanka: Supply chain stakeholders’ understanding and perspectives on prevalence
SAPS-075 - Medicine shortages in Sri Lanka: Causes, actions, and beyond
SAPS-076 - Pharmacists role in traditional and complementary medicine in Saudi Arabia: Professional responsibilities and needs
SAPS-077 - Tackling pharmaceuticals household waste in the United Arab Emirates
SAPS-078 - Co-designing a family centered medication management tool to support caregivers of medically complex children during the hospital to home transition period
SAPS-079 - Global collaboration to identify priority medicines in endocrinology: Development of applications for consideration by the WHO Expert Committee on the Selection of Essential Medicines
SAPS-080 - The European drug shortages formulary: monographs and technical recommendations to mitigate medicine shortages
SAPS-081 - Evaluation of the hub and spoke model for antimicrobial stewardship implementation
SAPS-082 - An assessment of the implementation of national AIDS/STI control programme 2019 consolidated guidelines for HIV care in antiretroviral therapy sites in Ghana: the pharmacists’ perspective
SAPS-083 - Qualitative study on public psychology in medical emergency decision-making: Focusing on clinical trial participation
SAPS-084 - Pragmatic evaluation of Alberta Pharmacy Care Clinics (PATIO Study): A survey exploring pharmacists experiences
SAPS-085 - Evaluating the effectiveness of the ‘Think Pharmacy First’ Campaign in the UK: Public awareness, engagement, and challenges in enhancing community pharmacy utilization
SAPS-086 - A conceptual framework for establishing a dedicated sport pharmacy service in health care systems
SAPS-087 - Exploring patient safety climate of Ontario hospital pharmacies in Canada
SAPS-088 - Challenges in accessing difficult-to-source medicines
SAPS-089 - Internet pharmacies serving the international community
SAPS-090 - Pharmaceutical policies and social participation in health: The role of official health conferences in Brazil
SAPS-091 - Factors influencing the careers of recent and upcoming PhD students in social and administrative pharmacy in the United States of America
SAPS-092 - Analysis of the satisfaction rate based on evaluation level by accreditation evaluation results of Korean pharmacy schools and factors affecting the accreditation evaluation results
SAPS-093 - An international portrait of pharmacists' professional role identities
SAPS-094 - Pharmacist Contribution to myHealth Portal
SAPS-095 - Pharmacist contribution in rare diseases
SAPS-096 - Risks and opportunities of digitalisation in pharmaceutical ecosystems: A SWOT analysis approach
SAPS-097 - Employment trends and determinants of career choices among Japanese pharmacy students
SAPS-098 - Optimization of hospital antimicrobial stewardship driven by digital intelligence technology: A practical study based on a 2200-bed tertiary hospital
SAPS-099 - Empowering healthcare professionals in anti-doping: A train-the-trainer approach
SAPS-100 - The pharmaceutical workforce in the Brazilian Public Health System trends: Growth in primary health care in the last decade (2014-2023)
SAPS-101 - Crisis preparedness and management in pharmaceutical scenarios
SAPS-102 - Initiation of advocating food and drug safety through interdisciplinary social practice in a University Social Responsibility (USR) project
SAPS-103 - Integrating sustainable development goals into pharmacy education: A pilot international learning network camp
SAPS-104 - Exploring pharmacy students’ awareness, attitudes, and preparedness toward deprescribing initiatives
SAPS-105 - Integrating clinical pharmacy teams into primary care provider (PCP): Improving workflow efficiency, reducing multitasking, and improving provider well-being
SAPS-106 - Expanding the pharmacists’ role in Brazil in the context of latent infection by Mycobacterium tuberculosis
SAPS-107 - Strategies implemented by the Federal Pharmacy Council to promote equity, inclusion, and diversity for the LGBTQIAPN+ and other vulnerabilized populations
SAPS-108 - Gender-based violence and harassment: the context of women pharmacists in Brazil. Preliminary study
SAPS-109 - Construction of teaching materials for a nationwide course on asthma for pharmacists in Brazil
SAPS-110 - Pharmacist-led prediabetes screening and education in New Orleans hospitality workers
SAPS-111 - Workplace wellness reimagined: Pharmacist-facilitated tools and care linkage for diabetes prevention
SAPS-112 - Exploring the ideal delivery of a patient-reported experience measure for medications in primary care in Ontario, Canada: A survey study
SAPS-113 - Exploring the use of patient-reported experience measures for medications in primary care in Ontario, Canada: A theory-based qualitative study
SAPS-113 - The policy process and legislative reform enabling pharmacy-led substitution of biological medicines in Finland
SIG - Drug delivery and manufacturing
DDM-001 - Integrative dermaceutical solutions: Development of camwood face cream, wash, toner & serum for improved dermatological health
DDM-002 - The effect of natural Emu Oil on inflammation induced in full-thickness human skin
DDM-003 - Ex vivo skin-permeation of ciclopirox olamine from different gels
DDM-004 - Multifunctional nanovesicle strategy for immune modulation and tumour-targeted therapy in metastatic melanoma
DDM-005 - Application of solid-lipid nanoparticles and pegylated solid dispersions to enhance delivery of nevirapine for HIV/AIDS management
DDM-006 - Enhancing targeted liver fibrosis therapy: Evaluating retinol-modified nanoparticles for Activated Hepatic Stellate Cells targeting and assessing atorvastatin- and JQ1-loaded NPs for effective aHSC deactivation
DDM-007 - Enhanced solubility and membrane permeability by coamorphous nanoparticles via co-precipitation of two drugs
DDM-008 - Real-world utilisation, efficacy, and safety of injectable GLP-1 receptor agonists: A drug use evaluation in Singapore's largest healthcare cluster
DDM-009 - In vitro release and safety study of the synthesized syringic acid loaded MIL-100(Fe) and modified MIL-100(Fe)
DDM-010 - Design of spray dried cyclodextrin-metal organic framework particles containing hydrophobic and hydrophilic compounds
DDM-011 - Artificial intelligence application for emulsion design and optimization utilising Microfluidics
DDM-012 - Expression and localisation of organic anion transporting polypeptide (Oatp) 2b1 in the term rat placenta
DDM-013 - Differences in the KATP channel-independent and endothelium-independent effects of pinacidil on bypass grafts from patients with type 2 diabetes mellitus
DDM-014 - Nose-to-brain delivery of cholecalciferol nanoparticles: A promising first-aid therapy for ischemic stroke
DDM-015 - The role of microRNAs in the treatment of multiforme glioblastoma: A systematic review
DDM-016 - Enhancement of alpha-lipoic acid solubility through cyclodextrin ternary complexation for improved therapeutic efficacy
DDM-017 -Improving the solubility and bioavailability of alpha-lipoic acid via hydroxypropyl-β-cyclodextrin complexation
DDM-018 - Modulation of P-glycoprotein expression and function in microglia: A drug barrier beyond the blood-brain barrier?
DDM-019 - Convolution approach to evaluate amiodarone-HCl solid oral dosage forms
DDM-020 - Simulated in-vivo behavior of indomethacin capsules
DDM-021 - Development of taste-masked orally dispersible tablets of metformin hydrochloride using spray drying and d-optimal design of experiments: Enhancing patient compliance
DDM-022 - Amorphous solid dispersions of Felodipine with various molecular weights of PEG's for dissolution enhancement using organic solvent-free supercritical CO2 processing: A green and sustainable technology
DDM-023 - Fabrication of 3D-dimensionally printed chewable tablets for pediatrics using hot melt extrusion coupled with direct extrusion: A cutting-edge green and sustainable technology for continuous manufacturing
DDM-024 - Formulation and characterisation of paracetamol-loaded 3D tablets with co-processed excipients using selective laser sintering
DDM-025 - High-Strength gelatin hydrogel scaffold with roxadustat loading remodels the inflammatory microenvironment to enhance osteoporotic bone repair
DDM-026 - Fabrication and characterization of a novel drug delivery platform for metastatic triple negative breast cancer
DDM-027 - Development of a Self-Emulsifying Drug Delivery System for Vitamin D3: A Novel Approach to Enhance Bioavailability
DDM-028 - Silica nanoparticle-based strategies to enhance atorvastatin: Improving solubility, bioavailability, and safety
DDM-029 - Evaluation of rutin-pregabalin combination in the treatment of neuropathic pain induced by nerve injury
DDM-030 - Development of Curcumin-Loaded Buccal Films Using Deep Eutectic Solvents: An Innovative Strategy for Enhanced Solubility and Mucosal Delivery
DDM-031 - The hidden benefits behind automating the comparative analysis of global proteomics datasets
DDM-032 - Evaluating the biological activities of novel nanoformulation for colorectal cancer treatment using optimised IncuCyte-based methodologies
DDM-033 - Dissolvable microneedles loaded with caffeine and adenosine for the treatment of Androgenetic Alopecia
DDM-034 - Targeting the TSP1/ TXR1 axis with metronomic micellar docetaxel to overcome chemoresistance in triple-negative breast cancer
DDM-035 - Synthesis and characterization of surface modified and stimuli responsive mesoporous silica nanoparticles loaded with Epigallocatechin Gallate (EGCG) for drug delivery applications
DDM-036 - Evaluating the efficacy of valproic acid-loaded lipid nanoparticles for nose-to-brain delivery using a 3D-printed nasal cast
DDM-037 - Bioinspired hydrogel without hormones for female-controlled on-demand prevention of unintended pregnancy
DDM-038 - AI-driven 3D drug printing: A new frontier in precision medicine and patient-centric drug development
DDM-039 - A sustainable sensor for hydroxychloroquine purity assessment: A quality-by-design approach
DDM-040 - ChemoGell - a thermosensitive injectable drug delivery vehicle for direct intratumoural delivery
DDM-041 - Preparation and evaluation of novel ascorbic acid-based thin film for nicotine cessation and cotinine detoxification
DDM-042 - Hypothetical ketoprofen plasma concentrations from dissolution data of multi-source capsules and a convolution approach
DDM-043 - Prediction of ibuprofen plasma levels from in-vitro release data of suspensions
DDM-044 - Process development of non-ionizing, microbial remediation for medicinal cannabis flower
DDM-045 - Tumor microenvironment-activatable copper MOF Nanoplatform triggers synergistic cuproptosis/ferroptosis via fenton catalysis for enhanced antitumor therapy
DDM-046 - apid systematic screening of bispecific antibody surrogate geometries for T-cell engagement using DNA nanotechnology.
DDM-047 - Ensuring Quality in Generic Pharmaceuticals: Dissolution Issues with Bulk Drug Powders
DDM-048 - Injectable thermoresponsive hydrogel for controlled drug delivery and regenerative treatment of volumetric muscle loss
DDM-049 - Development and validation of an ELISA assay to determine the potency of Androctonus Australis hector antivenom
DDM-050 - Assessment of detoxification methods of cerastes cerastes viper venom for antivenom manufacturing
DDM-051 - A comparative study of immunization protocols against rabies virus in rabbits
DDM-052 - Developing an optimized purification process for scorpion antivenom manufacturing
DDM-053 - A novel antioxidant based on carrot-derived nanovesicles alleviates oxidative stress for the treatment of osteoporosis
DDM-054 - Developing an innovative coamorphous salt formulation of telmisartan with amlodipine to enhance permeability and oral absorption
DDM-055 - Precision chemo-immunotherapy for cancer: A tumor microenvironment-responsive nano-delivery system
DDM-056 - Bioequivalence study of sodium valproate and valproic acid extended release tablets in healthy human volunteers
DDM-057 - Optimization and evaluation of fast disintegrating tablets containing Fructus Ligustri Lucidi extracts prepared by the direct compression method
DDM-058 - Combined blockade of lipid uptake and synthesis by CD36Inhibitor and SCD1 siRNA Is beneficial for the treatment of refractory prostate cancer
DDM-059 - Development and evaluation of biodegradable hydrogel-based bioadhesive for tissue engineering and surgical applications
DDM-060 - Automated Production of 18F-FDG: Targeted Cyclotron Production and Quality Control Procedures in South Africa
SIG - New generation of pharmaceutical scientists
NGPS-001 - Pharmacist-led and audit & feedback intervention to reduce antibiotic prescribing in primary care (AFA study)
NGPS-002 - A new participation model – early career pharmacists
NGPS-003 - Formulation and characterisation of chitosan-loaded Guiera Senegalensis nanoparticles for the treatment of Malaria
NGPS-004 - A supervised machine learning model for clinical decision support in asthma diagnosis
NGPS-005 - Evaluation of copper-dependent enzymes activity in a murine model of Menkes disease.
NGPS-006 - Non-animal approach in polyphenols research
NGPS-007 - Injecting oncolytic virotherapy for high-grade gliomas
NGPS-008 - Maternal tryptophan supplementation alters offspring gut-brain axis and behaviour in a sex-specific manner
NGPS-009 - Sustainable health education for pharmacy students: Leveraging interdisciplinary online learning and E-portfolios
NGPS-010 - Exploring the potential of digital pills for improving medication adherence
NGPS-011 - Advancing drug screening for Glioblastoma: The potential of 3D bioprinting
NGPS-012 - Establishment of a 3D culture model using patient-derived conditionally reprogrammed breast cancer cells and evaluation of their sensitivity to anticancer drugs
NGPS-013 - Phytochemical profile and in-vitro biological activity of novel Leonotis leonurus extracts on Monoamine oxidase B (MAO-B) – a drug target for depression.
SIG - New medicines
NMS-001 - Development of a novel Tetrabutylphosphonium-based Perindopril ionic liquid for film-based drug delivery in antihypertensive therapy
NMS-002 - Assessment of the safety and efficacy of romiplostim in live donor liver transplant recipients: A prospective randomised open label trial
NMS-003 - Design and optimisation of novel benzimidazole hybrid structures capable of simultaneous peroxisome proliferator activated receptor γ (PPARγ) and angiotensin receptor (ATR) modulation
NMS-004 - Drug design and optimisation at the Pregnane X receptor
NMS-005 - Drug Design and Optimisation at the IL-1 Receptor-Associated Kinase (IRAK)
NMS-006 - Drug design and optimisation at the dihydroorotate dehydrogenase (DHODH) receptor using the teriflunomide scaffold as a lead
NMS-007 - Drug Design and Optimisation of the Fibroblast Growth Factor Receptor Type 4(FGFR4)
NMS-008 - Evaluation of the anti-inflammatory and immunomodulatory effects of adipose-derived mesenchymal stromal/stem cells using imiquimod-induced psoriasis-like dermatitis model mice
NMS-009 - Design of novel molecules targeting breast cancer stem cells
NMS-010 - The biological active principles of fruit wine and its ability to prevent cell damage caused by free radicals
NMS-011 - The phenolic potential and antioxidant properties of newly created red grape variety in Serbia
NMS-012 - Synthesis of metformin complex with yttrium
NMS-013 - Transforming evidence into practice: Bisacodyl's dual approach to constipation treatment
NMS-014 - FXR agonist for post liver transplantation cholestasis: A randomized open-labelled study-preliminary results
NMS-015 - Comparative analysis of essential oils from solidago species in the flora of the Republic of Moldova
NMS-016 - Quinoline-naphthohydroquinone hybrid compounds: synthesis and biological evaluation
NMS-017 - Mechanism of lipid metabolism improvement by Lycium and Lycium-based polyherbal supplement polysaccharides in apolipoprotein E-deficient mice
NMS-018 - Non-Enzymatic microbial approach for curing Refsum’s Enzymatic disease
NMS-019 - Novel Triazole linked thymol-thienopyrimidine hybrids: In vitro and in silico studies
NMS-020 - Lactococcus lactis carrying staphylococcal protein A as a new weapon to fight against Methicillin Resistant Staphylococcus aureus skin and soft tissue infections
NMS-021 - Anti-neuroinflammatory effects and mechanism of exosome-like nanoparticles derived from Atractylodes lancea rhizome
NMS-022 - Factorial design applied in the stability analysis of epidermal substitutes for diabetic ulcer treatment.
NMS-023 - Construction and efficacy of an Ad5/casp3 adenoviral vector to induce apoptosis in MCF-7 cells as a potential advanced medicinal product for breast cancer
NMS-024 - An efficient model to optimize the production of cart cells in Mexico: An example for assume such a technology in non-developed countries
NMS-025 - CANnabidiol impact on challenging behaviour in adults with Intellectual disability with Lennox Gastaut and Dravet syndrome (CANABID-LD): A naturalistic case-control study
NMS-026 - Early positive signals for new treatments of primary hypercholesterolemia and mixed dyslipidemia: Bempedoic acid and inclisiran in Spain
NMS-027 - Evaluation of the immunoprotective power of a Multiple Antigenic Peptide against Aah II toxin of Androctonus australis hector scorpion
NMS-028 - A molecular docking and quantitative structure binding relationship study of sesquiterpene lactones as inhibitors of n. gonorrhoeae penicillin-binding protein 2 (PBP2h041) enzyme
NMS-029 - Comparative analysis of polyphenols in fruits and non-edible parts of aronia melanocarpa (MICHX.) Elliot from the republic of Moldova
NMS-030 - Evaluation of antiplasmodial and cytotoxic activity of harmisinins, harmine-artemisinin hybrids
NMS-031 - In-silico and In-vitro investigation of the molecular mechanisms of antiviral compounds for potentially inhibiting Dengue Virus NS2B-NS3 protease.
NMS-032 - SNP-6: A Novel Multi-Mechanistic Therapy for MASH with Evidence from Preclinical and Phase 2a study
SIG - Personalised and precision medicine
PPM-001 - The new pharmaceutical competence in oncology: Strengthening pharmaceutical differentiation and improvement patient-centred care
PPM-002 - Investigation of the application of pharmacogenomics in pediatric clinical practice
PPM-003 - Knowledge of physicians and pharmacists practicing in the Philippine General Hospital towards pharmacogenomics and its integration in clinical practice in the Philippines
PPM-004 - Mapping mutational profiles to drug sensitivity: A machine learning approach to precision medicine in diffuse intrinsic pontine glioma
PPM-005 - Developing a virtual clinical trials gulf population: Revolutionising precision dosing with virtual patients
PPM-006 - Tailoring cancer treatment: How virtual trials and advanced modelling improves imatinib dosing for obese patients
PPM-007 - Combination versus single-drug non-prescription analgesics for acute pain management: A narrative review
PPM-008 - RNA transcription assisted universal CRISPR/Cas12a system for programmable analysis of multiple colorectal cancer-associated microRNAs
PPM-009 - Causal relationship between inherited immune traits and cisplatin-induced ototoxicity in cancer patients: A bidirectional two-sample Mendelian randomization study
PPM-010 - Qualitative study on pharmacy-based pharmacogenetic testing opinions and perceptions among physicians, pharmacists and the Swiss general population
PPM-011 - Impact of genetic factors into bleeding events in patients taking direct oral anticoagulants (DOAC): Systematic review and meta analysis
PPM-012 - Impact of CYP450 Genotype and patient adherence on tamoxifen and its metabolites concentrations: A cross-sectional clinical investigation
PPM-013 - Biomarker-guided psychopharmacology: Advancing personalized medicine in mental health
PPM-014 - Pharmacists’ perspectives on implementing pharmacogenomics (PGx) in hospital practice: A survey on familiarity, application, and educational needs at a medical center in Taiwan
PPM-015 - Exposure to multiple drugs with actionable pharmacogenetic biomarkers among older adults in China: A retrospective analysis
PPM-016 - Clinical pharmacogenomics implementation in Thailand: The emerging roles of pharmacists in clinical setting
PPM-017 - Effects of cyclooxygenase inhibitors on prostaglandin E2 transport in the HK-2 human kidney epithelial cell line
PPM-018 - Assessment of knowledge, attitude, and practices of human ethics committee members on genetic data sharing and reuse for future research
PPM-019 - Development of a population pharmacokinetic model for high-dose methotrexate in Japanese paediatric patients with acute lymphoblastic leukaemia
PPM-020 - Application of popPK models for assessment of adherence to CDK4/6 inhibitor ribociclib
PPM-021 - Development of personalized fixed-dose anti-tuberculosis 3D printlets using selective laser sintering (SLS) additive manufacturing
PPM-022 - AI-driven precision medicine: Transforming pharmacy practice in Asia
PPM-023 - Integrating hypoxia-related gene signatures and machine learning to predict cetuximab resistance in colorectal cancer
PPM-024 - Development of a 3D-3 co-culture microbead consisting of cancer-associated fibroblasts and human umbilical vein endothelial cells for the anti-tumor drug assessment of lung cancer
PPM-025 - Synergizing artificial intelligence and telemedicine in pharmacotherapy of HIV-associated neurological disorders: A review from 2014-2024
PPM-026 - A point-of-care (POC) quantitative non-invasive test for liver dysfunction: Insights from animal and clinical trials
SIG - Pharmacy practice research
PPR-001 - Exploring the effectiveness of simulation-based teaching strategies on pharmacy interns' learning outcomes in resolving injectable drug compatibility issues
PPR-002 - Bridging the gap in Hepatitis C virus cascade of care in Africa using community pharmacies: A feasibility and implementation study
PPR-003 - Monitoring and Optimizing Adherence to GLP-1 Analogue Therapy: The Role of Community Pharmacy Interventions
PPR-004 - Advancing pain management in tertiary care through pharmacoeconomic evaluation and strategic pharmacist-led interventions in clinical practice
PPR-005 - Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder: Experience of Australian clinicians, researchers and patients
PPR-006 - The vulnerable populations’ inclusiveness in pharmaceutical care (VIP-Care) Project: Validating a battery of tests and assessing pharmacists’ attitudes in community setting
PPR-007 - Implementing community pharmacist-assisted medical teleconsultations
PPR-008 - Pharmacist-led intervention and audit & feedback to reduce inappropriate medication prescriptions in patients over 65 years of age in primary care: The AIM study
PPR-009 - A qualitative study to refine and finalize the MedManageSCI prototype: A web-based toolkit to support medication self-management in adults with spinal cord injury/dysfunction
PPR-010 - Co-design and prototype development of MedManageSCI: A medication self-management toolkit for adults with spinal cord injury/ dysfunction
PPR-011 - Enhancing clinical pharmacy training in resource-limited settings: An international pharmacy practice residency program with a layered learning approach
PPR-012 - Testing, prevention, collaboration: A multi-methods study of a Canadian pharmacist-led model for HIV, HCV and syphilis testing (APPROACH 2.0)
PPR-013 - The career aspirations of overseas pharmacists planning to qualify and work in the UK
PPR-014 - Applying the necessity-concerns framework to determine the effect of an educational intervention on type 2 diabetes mellitus treatment adherence in Jos, Nigeria
PPR-015 - Interrupting and distracting pharmacists when dispensing - what are the consequences? A scoping review of the impact of interruptions and distractions in pharmacy practice.
PPR-016 - Pharmacists as wellness and preventive medicine advocates (WPMA): A framework for corporate and community-based health promotion in Africa
PPR-017 - Adherence to guideline - based peri-operative antibiotic prophylaxis in cesarean section: A retrospective study in a tertiary care hospital
PPR-018 - Monotherapy versus dual lipid-lowering therapy in high-risk coronary artery disease patients
PPR-019 - Enhancing medication safety in pharmacy practice: An AI-driven digital health solution to reduce adverse drug reactions and self-medication risks
PPR-020 - Pharmacy workforce wellbeing survey in Great Britain
PPR-021 - The role of pharmacists in antimicrobial stewardship
PPR-022 - Empowering pharmacists to generate evidence in practice: Development of a training programme
PPR-023 - Key challenges in hospital pharmacy practice in Turkey: A global comparison
PPR-024 - Clinicians’ views on the culturally safe implementation of a transition of care stewardship service for First Nations patients on discharge: A qualitative study
PPR-025 - Discharge interventions and their cultural adaptations for first nations peoples: a systematic review
PPR-026 - Psychological predictors of self-medication with antibiotics among postpartum women in Tema, Ghana: Insights from the health belief model
PPR-027 - Collaborative drug therapy management enhances both the value of pharmacists and patient experience
PPR-028 - Community pharmacist influenza vaccination sandbox: Empowering Singapore’s pharmacists in providing vaccination service
PPR-029 - Naloxone availability in Australian community pharmacies 2015- 2025: Policy impacts and changes over time
PPR-030 - Contribution of dispensing in community pharmacies to medication safety: development of a comprehensive generic model
PPR-031 - Impact of a pharmacist-led education program on knowledge in patients admitted with an acute heart failure: A randomized clinical trial (Educ-HF)
PPR-032 - Clinical pharmacy services provided via telemedicine to justice-involved individuals
PPR-033 - Validation of MEDRISK: Medication Evaluation and Determination of Risk Stratification tool
PPR-034 - Development and feasibility of a telehealth system (Impak Sihat) to empower rural population in Malaysia on the quality use of medicines
PPR-035 - Perceptions of pharmacists about primary care pharmaceutical services provided to young people with chronic illness
PPR-036 - Exploring the experience of pharmacists about pharmacy services for young people in primary care: A cross-sectional study
PPR-037 - Application of green practices within the distribution sector
PPR-038 - Identifying barriers: monitoring the implementation process of reimbursed clinical pharmacy services in community pharmacies
PPR-039 - Determinants of digital health technology adoption intentions among Lebanese pharmacy students
PPR-040 - Knowledge, attitudes, and practices regarding environmental sustainability: Are pharmacy students prepared to address the climate crisis?
PPR-041 - The introduction of implementation agent for pharmacy services in community pharmacy in Croatia
PPR-042 - The Case of the Missing Clinical Pharmacy Services in Private Hospitals: A Qualitative Study from Qatar and the Gulf
PPR-043 - Qualitative assessment of challenges in reporting adverse events in clinical trials: A site management office perspective
PPR-044 - Trends in menopausal hormone therapy dispensing in Australia between 2014 and 2023
PPR-045 - Identification and management of pharmaceutical care issues in a pediatric critical care unit in Ghana: A pharmacist-led initiative
PPR-046 - Breaking down barriers to contraception: Pharmacists as prescribers
PPR-047 - Analyzing nephrotoxic burden and acute kidney injury in adult patients admitted to non-intensive care units at two hospital systems
PPR-048 - From plan to practice: Using implementation mapping to develop theory based, adaptable and context appropriate implementation strategies for the delivery of myCare Start in Switzerland
PPR-049 - A smarter start: Adaptation of the new medicine service to form Switzerland’s mycare start service using a context-driven and stakeholder led co-creation approach
PPR-050 - The Canadian travel health landscape: Current education needs and practices and future directions identified by pharmacists experienced in travel health
PPR-051 - Pharmacy-based injection services scheduled outside of typical operating hours of other primary care providers: An analysis of 1.2 million injections administered in Canadian community pharmacies
PPR-052 - Trends in increased blood pressure in Pune, India: A comparative 10 year assessment
PPR-053 - Telepharmacy in Asia: Transforming access to healthcare and pharmacist-driven patient care
PPR-054 - Community pharmacy-based testing and treatment for chlamydia trachomatis and neisseria gonorrhoeae (Swab-Rx Study)
PPR-055 - Barriers and Facilitators to pharmacist contraception prescribing in British Columbia: A qualitative approach
PPR-056 - Vascular age as a key for a team-based approach to manage blood pressure bridging community pharmacists and primary healthcare physicians: The TOGETHER cluster-randomised trial
PPR-057 - Impact of an educational intervention on knowledge of surgical antibiotic prophylaxis among healthcare workers: A pre- and post-intervention study
PPR-058 - Preliminary investigation and analysis of the awareness and implementation of risk management plans among pharmacists in Taiwan
PPR-059 - Building trust in AI: A community-engaged approach to addressing health disparities
PPR-060 - Quality use of medicines: From national policy to local implementation in Saudi Arabia
PPR-061 - Using two large language models to classify guidelines in clinical decision support systems
PPR-062 - Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation
PPR-063 - Implementation and impact of pharmacist prescribing of hormonal contraceptives in Brazil: Enhancing women's access and autonomy
PPR-064 - The impact of pharmacist involvement in antimicrobial stewardship for COPD Patients: A scoping review
PPR-065 - Common upper respiratory ailments and findings from STAR 2 – opportunities for pharmacists to support appropriate management and reduce antibiotic use
PPR-066 - Advocating for a pharmacist’s role in future services for methamphetamine use disorder
PPR-067 - Effectiveness of a collaborative deprescribing intervention of potentially inappropriate proton-pump inhibitors among community-dwelling older adults: The C-SENIoR trial
PPR-068 - Enhanced patient information access improves pharmacists' ability to identify drug related problems: A mixed-methods study
PPR-069 - Adherence of developing countries to good pharmacy practice: A systematic review and meta-analysis
PPR-070 - Early detection and management of anemia in pre-dialysis chronic kidney disease patients in Qatar: A real-world retrospective cohort study
PPR-071 - Needs assessment for early career pharmacists in a low-income country: A case study of Sierra Leone
PPR-072 - An investigation of the prevalence and risks of Outpatient Parenteral Antimicrobial Therapy (OPAT) in patients undergoing long-term management
PPR-073 - Knowledge, attitudes, and practices of community pharmacists on patient counselling: A cross-sectional study in Gampaha District, Sri Lanka: A study protocol
PPR-074 - Knowledge and practices of government pharmacists and dispensers regarding pharmaceutical care in Northern Province, Sri Lanka: A cross-sectional study
PPR-075 - Patient practices and attitudes toward disposal of unused pharmaceuticals: A cross-sectional study at District General Hospital, Kegalle, Sri Lanka
PPR-076 - The vital role of clinical pharmacists in improving the application of Guidelines Directed Medication Therapy (GDMT) in the heart failure program
PPR-077 - Association between inhaled corticosteroid particle size and respiratory tract infections in asthma patients
PPR-078 - Grading outcomes of pharmacy self-inspections vs. Inspection: A risk-based approach to pharmacy inspections in South Africa
PPR-079 - Operational workflow and learnings from first national central fill pharmacy under national pharmacy strategy initiative 3.2
PPR-080 - How can community pharmacists support comprehensive geriatric assessment
PPR-081 - Effect of pharmacist-led interventions in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials
PPR-082 - The impact of pharmaceutical care on quality of life in patients using psychotropic medicines
PPR-083 - Embedding Inclusive Pharmacy Practice (IPP) in 2025: Creating A Sense of Belonging Across Pharmacy Teams in England
PPR-084 - The Northern Ireland Medicines Optimisation Innovation Centre (MOIC): A decade of impact
PPR-085 - Medication management of patients with cancer undergoing surgery from preadmission to discharge: A multi-method study
PPR-086 - A clinical pharmacist approach to alcohol: Implications for training
PPR-087 - Vaccine compliance and prevention of related infections during Lebanon's hardships in a tertiary hospital
PPR-088 - What can be learned about problems in medication use in Denmark through medication talks in Danish pharmacies?
PPR-089 - Pharmacy services in South Africa: Who performs them?
PPR-090 - Reimbursement of pharmaceutical services provided in pharmacies in South Africa
PPR-091 - Do community pharmacies unnecessarily recommend oral emergency contraception? A nationwide mystery caller investigation in Germany
PPR-092 - Future Initiation of pharmacist-led nonprofit ambulatory care clinics in remote areas of South Asia and the Middle East
PPR-093 - Primary care facility use of antimicrobial during management of respiratory tract infection and diarrhoea in Zimbabwe: Promoting stewardship at primary care
PPR-094 - Identifying factors of success in implementing an intervention for management of inpatient bacteriuria in four regional hospitals in Nova Scotia
PPR-095 - Perspectives on pharmacist-physiotherapist collaboration for acute musculoskeletal injuries
PPR-096 - Patient perceptions of pharmacist-led primary care
PPR-097 - Barriers and facilitators to access and acceptance of digital health interventions among people experiencing homelessness: a systematic scoping review
PPR-098 - Assessing the knowledge, attitudes and practices of healthcare staff and students regarding disposal of unwanted medications: a systematic review
PPR-099 - Digital transformation in medicines management in Malawi: A user-centered approach to eMMS development
PPR-100 - Pharmacist attendance on ward rounds: a survey of medical officer and pharmacist perspectives
PPR-101 - Healthcare professionals' insights on interprofessional collaboration in the myCare Start service
PPR-102 - Identification of medication therapy problems through a patient medication counseling program in a tertiary government hospital
PPR-103 - A single-center observational study on treatment satisfaction In patients with psoriasis and vitiligo
PPR-104 - Precision in practice: Evaluating chemotherapy dose adjustments in cancer patients at a major Sydney tertiary hospital
PPR-105 - Capacity building for pharmacists and other healthcare professionals in advanced therapy medicinal products: a systematic review
PPR-106 - Pharmacists’ knowledge, attitudes, and confidence in recommending mobile health applications to patients: What we learned from the literature
PPR-107 - Pharmacy professionals' perception of best practices and challenges in fulfilling the national association of pharmacy regulatory authorities model standards for pharmacy compounding in Canada
PPR-108 - Engaging pharmacists, pharmacy technicians and pharmacy students to take action to tackle antimicrobial resistance: 10-years of the Antibiotic Guardian campaign
PPR-109 - Utilisation patterns and quality of lipid control among patients prescribed lipid-lowering therapies in primary care settings in Kuwait: A nationwide cross-sectional study
PPR-110 - Analysis of drug therapy for the treatment of type 2 diabetes mellitus by measuring drug utilization in Bulgaria
PPR-111 - Young pharmacists as tomorrow’s decision-makers in Lebanon: Tools validation and perceptions of pharmaceutical policymaking and public service motivation
PPR-112 - Advancing global pharmacy workforce development: A comprehensive review of competency frameworks
PPR-113 - Point-of-care testing as a tool in community pharmacy practice to identify and flag undiagnosed diabetes and cardiovascular risk factors: An observational study
PPR-114 - Impact of continuing education on immunization rates in a community pharmacy setting
PPR-115 - Assessing intellectual humility among healthcare students: An interprofessional comparative study
PPR-116 - An exploration of hospital prescribers’ perceptions of design features of electronic health record systems and the impact on decision-making: A multi-site qualitative study
PPR-117 - Risk of severe exacerbation associated with Gabapentinoid use in patients with Chronic Obstructive Pulmonary Disease: A population-based cohort study
PPR-118 - Trends in the prescription of central nervous system depressants in patients with Chronic Obstructive Pulmonary Disease in the United Kingdom Primary Care, 2000 – 2022
PPR-119 - Patient-centered clinical practice on Lymphangioleiomyomatosis
PPR-123 - Healthcare professionals’ perceptions and practices of medication reconciliation as a medication safety strategy
PPR-124 - Pharmacy students’ and professionals’ knowledge, perception and attitude of sustainability in pharmacy practice: A systematic review
PPR-125 - The effect of weight-lowering drugs on natural fertility in women with overweight and obesity: A systematic review
PPR-126 - Underlining the pharmaceutical waste problem in the United Kingdom and the strategies in place to combat it
PPR-127 - Effect of Metformin on the risk of post-COVID-19 condition among individuals with overweight and obesity in the United Kingdom: A population-based retrospective cohort study
PPR-128 - Through Lebanese eyes: Understanding Multiple Sclerosis knowledge and attitudes
PPR-129 - Filling prescriptions but missing outcomes: Lithuania’s E-adherence dilemma
PPR-130 - We want to engage in projects where our customers truly benefit: Attitudes among pharmacy staff towards research in the Danish community pharmacy setting
PPR-131 - Community pharmacists' contribution to lifestyle improvements: Insights, perspectives, and best practices from the lifestyle pharmacist network in the Netherlands
PPR-132 - SHAP-based predictive modeling of all-cause readmission risk in heart failure patients during the post-discharge vulnerable period
PPR-133 - The roles and responsibilities of healthcare professionals in collaborative medication reviews: A Delphi consensus study
PPR-134 - The impact of point of care testing in patients with diabetes receiving a medication review
PPR-136 - A review of the role of artificial intelligence in pharmacovigilance and patient safety in Egypt
PPR-137 - Pharmacist Prescribing Support for Antiviral Drugs for New Coronavirus Infections in Outpatient Fever Clinics
PPR-138 - Does medicine optimisation work for older people from ethnic minority communities with polypharmacy and their informal carers in primary care?
PPR-139 - Potential cost-effectiveness of pharmacist-led benzodiazepine deprescribing for elderly
PPR-140 - A systematic review of pharmacist-administered paediatric vaccinations in low- and low-middle-income countries.
PPR-141 - Rural community vaccination barriers during the COVID-19 pandemic
PPR-142 - Behavioural skills in community pharmacy: Exploring their role in patient care and interactions from the perspectives of patients and pharmacists
PPR-143 - New indication, more use: Amplifying early positive signals for tirzepatide in Spain
PPR-144 - Developing pharmacist-led anticoagulation clinics in primary care settings in Qatar: A multiphase mixed-method study
PPR-145 - The cost of treating selected psychiatric conditions from the provider’s perspective in a public tertiary academic hospital in South Africa
PPR-146 - Tablet administration and associated factors in elderly dysphagic patients in Norwegian nursing homes
PPR-147 - Pharmacists’ role in reducing medicine waste: Barriers, solutions, and sustainable practices in Norwegian community pharmacies
PPR-148 - A multisite implementation-efficacy trial of a community pharmacist-led model of collaborative care for medication assisted treatment for opioid dependence: 6-month outcomes of the EPIC-MATOD trial
PPR-149 - Advancing pharmaceutical immunization services through continuing education in community pharmacies
PPR-150 - Advancing hospital pharmacy in Sri Lanka: An online survey on pharmacists’ perspectives on their roles in public sector hospitals
PPR-151 - Hydroxyurea therapy in Sickle Cell disease patients: Availability, adherence and treatment outcomes
PPR-152 - Enhancing adolescent guidance: Communication practices for over-the-counter analgesics in Norwegian pharmacies
PPR-153 - Enhancing asthma and COPD management: Aligning pharmacy services with patient needs and expectations
PPR-154 - Patients’ experiences with Medisinstart: Benefits and areas for improvement in a Norwegian pharmacist-led service
PPR-155 - Effectiveness of Chinese herbal medicine on haematological outcomes in colorectal cancer patients receiving irinotecan-based chemotherapy: A retrospective propensity score matching-adjusted analysis
PPR-156 - Holistic pain management: Leveraging real-world data in the context of the analgesic ladder
PPR-157 - Integrating self-healing into musculoskeletal pain management: Role of pharmacists
PPR-158 - Antifungal Agents trends of utilization, spending, and prices in the US Medicaid Programs: 2009 – 2023
PPR-159 - An evaluation of pre-post antimicrobial stewardship intervention studies utilizing the Kirkpatrick model across healthcare education levels: A scoping review
PPR-160 - Digitalization in curriculum of pharmaceutical science education
PPR-161 - Pharmacist-assessed adherence and quality of life in patients with epilepsy
PPR-162 - Exhaustive computational analysis of pyrimidine derivatives as GPR119 agonists for the treatment of Type 2 Diabetes Mellitus
PPR-163 - Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer Compared to Chemotherapy Alone: A Multi-Centre Retrospective Study
PPR-165 - Leveraging of artificial intelligence to enhance medication adherence: A pharmacy perspective
PPR-166 - Investigating structural features of curcumin-derived CK2 inhibitors for anticancer therapy: A 3D-QSAR, pharmacophore modelling, virtual screening, and molecular docking approach
PPR-167 - Indispensable role of pharmacists in pre-end-stage renal disease (pre-ESRD) management: New prospects for health policy formulation
PPR-168 - Ethical Dilemmas in Dispensing Nervous System Medication: Justice, Socio-Availability, and Adherence.
PPR-169 - Occurrence of polypharmacy and its relationship with comorbidities: A descriptive cross-sectional study from a secondary care clinic setting in Sri Lanka
PPR-170 - Do demographic factors affect medication knowledge and adherence among bipolar disorder patients? Insights from outreach clinics conducted by National Institute of Mental Health, Sri Lanka.
PPR-171 - The relationship between medication adherence and Fasting Blood Sugar level among diabetes patients on oral antidiabetics. An analytical cross-sectional study from Southern province, Sri Lanka.PPR-112
PPR-172 - Development and evaluation of a fall prevention flipchart as a pharmacist-provided counselling material
SIG - Pharmacy Technicians
PTS-001 - May the 4s be with you
PTS-002 - The impact of education, training, enablers and facilitators on the scope of practice of pharmacy, dental, and optical professionals in GB/UK: A scoping review protocol
PTS-003 - Stock data insights – Reducing waste and improving dialogues
SIG - Regulatory Sciences and Quality
RSQ-001 - Unlocking possibilities in pharmacy practice: The nexus between practice, policy, and education
RSQ-002 - CT-Luso – Ethics and regulatory capacity building partnership for clinical trials in Portuguese-speaking African countries
RSQ-003 - Pharmaceutical track and trace (E-Pedigree) technology: Challenges and opportunities for pharmacists
RSQ-004 - Assessment of therapeutic equivalence of levothyroxine sodium in pharmaceutical tablets in Lebanon via novel analytical techniques: Quantitative analysis, in vitro release and tablet mapping
RSQ-006 - Comparison of treatment effects between ACR response criteria and target-based outcomes for contemporary rheumatoid arthritis drug approval trials: A meta-epidemiological study
RSQ-007 - Qualification of MFDS Reference Standards (RS): Confirmation of quality suitability and assignment of characteristic values
RSQ-008 - On-line and off-line SPE in drug analysis from biological material: A comparison based on green analytical chemistry approach
RSQ-009 - The contribution of signal detection in promoting safety, quality and efficacy of medical devices
RSQ-010 - Antihypertensive activity of ethyl acetate fraction of Hydrocotyle javanica Thunb. in anaesthetised spontaneously hypertensive rats
RSQ-011 - An evaluation of a systematic quality signal extraction framework in medicinal products regulatory sciences
RSQ-012 - Regulatory oversight of patient safety in medical devices
RSQ-013 - Cost-effectiveness analysis of neoadjuvant chemotherapy regimens EC-T vs. FAC for breast cancer in Indonesia
RSQ-014 - Challenges in accessibility to CE marked medical devices within the European Union
RSQ-015 - Capacity building in the medical device regulatory inspectorate
RSQ-016 - Regulatory CMC submission challenges and recommendations for synthetic oligonucleotides and RNA therapies
RSQ-017 - Assessment of niacinamide content in commercial skin care products
RSQ-018 - Challenges of performing clinical trials
RSQ-019 - Regulation of food supplements
RSQ-020 - Extended stability evaluation of dexrazoxane solutions: implications for prolonged clinical administration
RSQ-021 - In-syringe polypropylene fiber-supported liquid-phase microextraction for determination of tyrosine kinase inhibitors by LC-MS
RSQ-023 - SWOT analysis of the pharmaceutical supply chain in Saudi Arabia: challenges and opportunities in the era of vision 2030
RSQ-024 - Content of hydroxyanthacene glycosides in the products of senna available on the market
RSQ-025 - Good clinical practices in regulated and semi-regulated market: A comparative analysis
RSQ-026 - The impact of global clinical trial harmonization initiatives in Botswana
Various
VRS_001 - Action research on athletes’ need for information to avoid inadvertent doping (work in progress)
VRS_002 - Change in childhood vaccine-preventable infection rates before and after COVID-19 pandemic and the attitude of parents toward childhood vaccination
VRS_003 - Influence of GLP1 receptor agonists on cardiovascular disease: A review from ClinicalTrials.gov
VRS_004 - Canertinib induces apoptosis in KRAS mutant colorectal cancer cells via SGK1 downregulation and FBXO32 upregulation
VRS_005 - Exploring the synergistic potential of statins and doxorubicin in colon cancer treatment: effects on sw-620 cell proliferation and apoptosis
VRS_006 - Effects of ripe tomato saponin esculeoside A in mice colorectal cancer models
VRS_007 - Health literacy and understanding of pharmacists' instructions among urban and rural patients: A survey-based study
VRS_008 - Shaping the future of cell therapies in Portugal: Defining a strategic agenda for improved access and policy development
VRS_009 - Antimicrobial susceptibility testing of Klebsiella pneumoniae recovered from urine samples
VRS_010 - Is early life exposure of male infants to acetaminophen impeding testicular development and functions? A concern supported by animal and human studies
VRS_011 - Making medicines safer for pregnancy: How pharmacokinetic modelling is transforming drug safety through real-world case studies
VRS_012 - Integrating graph convolutional networks and computational chemistry for pharmaceutical multicomponent crystal prediction and classification
VRS_013 - Cancer treatment focusing on cytotoxicity induction by combined use of nadifloxacin and UVA irradiation
VRS_014 - Experiences of innovative alternative medicine therapy, ortho-cellular nutrition therapy (OCNT) in community pharmacy
VRS_015 - Novel controlled release nano-microneedles system combined with photodynamic therapy for malignant melanoma treatment
VRS_016 - Efficacy of GLP-1 analogues in the treatment of obesity
VRS_017 - Prototyping of biofunctionalized labor monitoring equipment using 5G communication
VRS_018 - Berberine Inhibits ISG15 and pyroptosis to attenuate diabetic kidney disease inflammation and fibrosis
VRS_019 - Medicines shortages: A comprehensive assessment of the causes and impact with recommendations for collaborative action.
VRS_020 - Needs assessment for a local pharmaceutical stockpile in the municipality of Bergen, Norway
VRS_021 - Academic detailing service as a form of educational outreach to enhance evidence-based drug therapy prescribing in primary care
VRS_022 - The impact of academic detailing on primary care providers and menopause management
VRS_023 - A case report of drug-induced liver injury (DILI) in a cervical cancer patient treated with toripalimab combined with chemotherapy
VRS_024 - Exploring community-based pharmaceutical care: Identifying new medical problems due to deviations in medication adherence behaviour
VRS_025 - Enhancing medication understanding in patient and efficiency in community pharmacy with thermal-printed dispensing labels and colour-coded envelopes: The T-label initiative
VRS_026 - The collaboration of pharmacists from seperate health institutions through PharmaCloud System: awareness, evaluation of the suspected ADR induced by Donezepril
VRS_027 - Analysis of changes in Montreal cognitive assessment scores after pharmacist-led medication counseling in patients taking anti-dementia drugs
VRS_028 - Comparative study on adverse drug reactions (ADRs) and adverse drug reaction (ADR) reporting amongst staff of two organizations in Lagos State, Nigeria
VRS_029 - Vitamin K2 as an immunomodulator: evidence from an animal model of rheumatoid arthritis
VRS_030 - Adherence and persistence among patients with type 2 Diabetes initiating glucagon-like peptide-1 receptor agonists: A real-world study in China
VRS_031 - Characteristics, comorbidities, and prescription medication treatment in Chinese patients with osteoporosis: A cross-sectional study
VRS_032 - Increasing polypharmacy and medication use among patients with Diabetes: 2015-2021
VRS_033 - Effectiveness of unfractionated heparin vs enoxaparin in ARDS and metabolic dysfunction: A comparative study
VRS_035 - Penicillin allergy delabelling guidelines: A global comparison of scope and recommendations
VRS_036 - Global quality of penicillin allergy delabelling guidelines: An AGREE II appraisal
VRS_037 - Penicillin allergy delabelling: A rapid overview of reviews and future directions for a living evidence base
VRS_038 - Is the only content of hyaluronic acid sufficient for evaluating commercial artificial tears?
VRS_039 - Adjuvant care: Case of ozone therapy
VRS_040 - Butyrate inhibits the progression of idiopathic pulmonary fibrosis by upregulating YBX1
VRS_041 - Construction of a lung cancer 3D culture model based on alginate/ gelatin micro-beads for drug evaluation
VRS_042 - Can AI use a smoker’s personality to predict quit success?
VRS_043 - An assessment of availability, price and affordability of selected essential medicines for stroke management at the primary health care level in Ghana
VRS_044 - A systematic review of clinical practice guidelines on how to deprescribe medications in older persons
Please note that the presentation file is not available yet.
PDF will be available to FIP members and congress participants.